10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2025

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to             

Commission file number 001-34504

ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	20-5340172
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
6303 Cowboys Way, Suite 600 Frisco, TX	75034
(Address of principal executive offices)	(Zip Code)

(469) 535-8200

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value	ADUS	The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

1

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☒	Accelerated Filer	☐
Non-Accelerated Filer	☐	Smaller Reporting Company	☐
Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of  July 29, 2025, Addus HomeCare Corporation had 18,407,239 shares of Common Stock outstanding.

2

ADDUS HOMECARE CORPORATION

FORM 10-Q

INDEX

PART I. FINANCIAL INFORMATION	4
Item 1. Financial Statements (Unaudited)	4
Condensed Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024	4
Condensed Consolidated Statements of Income For the Three and Six Months Ended June 30, 2025 and 2024	5
Condensed Consolidated Statement of Stockholders’ Equity For the Three and Six Months Ended June 30, 2025 and 2024	6
Condensed Consolidated Statements of Cash Flows For the Six Months Ended June 30, 2025 and 2024	8
Notes to Condensed Consolidated Financial Statements	9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3. Quantitative and Qualitative Disclosures About Market Risk	40
Item 4. Controls and Procedures	40
PART II. OTHER INFORMATION	41
Item 1. Legal Proceedings	41
Item 1A. Risk Factors	41
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	41
Item 3. Defaults Upon Senior Securities	41
Item 4. Mine Safety Disclosures	41
Item 5. Other Information	41
Item 6. Exhibits	42

3

PART I – FINANCIAL INFORMATION

Item 1.         Financial Statements

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

As of June 30, 2025 and December 31, 2024

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)

	June 30, 2025		December 31, 2024
Assets
Current assets
Cash	$	91,176	$	98,911
Accounts receivable, net of allowances		140,098		122,880
Prepaid expenses and other current assets		31,771		38,591
Total current assets		263,045		260,382
Property and equipment, net of accumulated depreciation and amortization		24,441		24,703
Other assets
Goodwill		969,824		970,558
Intangibles, net of accumulated amortization		105,656		109,643
Operating lease assets, net		45,965		47,348
Total other assets		1,121,445		1,127,549
Total assets	$	1,408,931	$	1,412,634
Liabilities and stockholders' equity
Current liabilities
Accounts payable	$	15,687	$	27,176
Accrued payroll		68,441		62,053
Accrued expenses		33,054		28,959
Operating lease liabilities, current portion		12,969		12,800
Government stimulus advances		7,927		11,239
Accrued workers' compensation insurance		13,305		13,644
Total current liabilities		151,383		155,871
Long-term liabilities
Long-term debt, less current portion, net of debt issuance costs		169,059		218,443
Long-term operating lease liabilities		40,223		41,883
Deferred income tax		26,287		25,820
Other long-term liabilities		125		125
Total long-term liabilities		235,694		286,271
Total liabilities	$	387,077	$	442,142
Stockholders' equity
Common stock—$.001 par value; 40,000 authorized and 18,407 and 18,148 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	$	18	$	18
Additional paid-in capital		602,126		594,044
Retained earnings		419,710		376,430
Total stockholders' equity		1,021,854		970,492
Total liabilities and stockholders' equity	$	1,408,931	$	1,412,634

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

4

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

For the Three and Six Months Ended June 30, 2025 and 2024

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)

	For the Three Months Ended						For the Six Months Ended
	June 30,						June 30,
	2025			2024			2025			2024
Net service revenues	$	349,443		$	286,922		$	687,151		$	567,668
Cost of service revenues		235,566			193,764			465,597			386,333
Gross profit		113,877			93,158			221,554			181,335
General and administrative expenses		77,077			63,576			150,297			124,639
Depreciation and amortization		3,913			3,401			7,856			6,870
Total operating expenses		80,990			66,977			158,153			131,509
Operating income		32,887			26,181			63,401			49,826
Interest income		(583	)		(474	)		(1,085	)		(897	)
Interest expense		3,525			2,114			7,543			4,872
Total interest expense, net		2,942			1,640			6,458			3,975
Income before income taxes		29,945			24,541			56,943			45,851
Income tax expense		7,893			6,462			13,663			11,942
Net income	$	22,052		$	18,079		$	43,280		$	33,909
Net income per common share
Basic income per share	$	1.22		$	1.12		$	2.40		$	2.10
Diluted income per share	$	1.20		$	1.10		$	2.36		$	2.06
Weighted average number of common shares and potential common shares outstanding:
Basic		18,045			16,177			18,011			16,120
Diluted		18,332			16,498			18,340			16,449

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

5

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the Three and Six Months Ended June 30, 2025

(Amounts and Shares in Thousands)

(Unaudited)

	For the Three Months Ended June 30, 2025
						Additional				Total
	Common Stock					Paid-in		Retained		Stockholders'
	Shares			Amount		Capital		Earnings		Equity
Balance at April 1, 2025		18,399		$	18	$	597,706	$	397,658	$	995,382
Issuance of shares of common stock under restricted stock award agreements		10			—		—		—		—
Forfeiture of shares of common stock under restricted stock award agreements		(2	)		—		—		—		—
Stock-based compensation		—			—		4,420		—		4,420
Shares issued for exercise of stock options		—			—		—		—		—
Net income		—			—		—		22,052		22,052
Balance at June 30, 2025		18,407		$	18	$	602,126	$	419,710	$	1,021,854

	For the Six Months Ended June 30, 2025
						Additional				Total
	Common Stock					Paid-in		Retained		Stockholders'
	Shares			Amount		Capital		Earnings		Equity
Balance at January 1, 2025		18,148		$	18	$	594,044	$	376,430	$	970,492
Issuance of shares of common stock under restricted stock award agreements		237			—		—		—		—
Forfeiture of shares of common stock under restricted stock award agreements		(3	)		—		—		—		—
Stock-based compensation		—			—		7,590		—		7,590
Shares issued for exercise of stock options		25			—		492		—		492
Net income		—			—		—		43,280		43,280
Balance at June 30, 2025		18,407		$	18	$	602,126	$	419,710	$	1,021,854

6

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the Three and Six Months Ended June 30, 2024

(Amounts and Shares in Thousands)

(Unaudited)

	For the Three Months Ended June 30, 2024
						Additional				Total
	Common Stock					Paid-in		Retained		Stockholders'
	Shares			Amount		Capital		Earnings		Equity
Balance at April 1, 2024		16,370		$	16	$	406,465	$	318,662	$	725,143
Issuance of shares of common stock under restricted stock award agreements		8			—		—		—		—
Forfeiture of shares of common stock under restricted stock award agreements		(3	)		—		—		—		—
Stock-based compensation		—			—		2,855		—		2,855
Shares issued for exercise of stock options		—			—		—		—		—
Shares issued in Public offering, net of offering costs		1,725			2		175,576		—		175,578
Net income		—			—		—		18,079		18,079
Balance at June 30, 2024		18,100		$	18	$	584,896	$	336,741	$	921,655

	For the Six Months Ended June 30, 2024
						Additional				Total
	Common Stock					Paid-in		Retained		Stockholders'
	Shares			Amount		Capital		Earnings		Equity
Balance at January 1, 2024		16,227		$	16	$	403,846	$	302,832	$	706,694
Issuance of shares of common stock under restricted stock award agreements		151			—		—		—		—
Forfeiture of shares of common stock under restricted stock award agreements		(3	)		—		—		—		—
Stock-based compensation		—			—		5,474		—		5,474
Shares issued for exercise of stock options		—			—		—		—		—
Shares issued in Public offering, net of offering costs		1,725			2		175,576		—		175,578
Net income		—			—		—		33,909		33,909
Balance at June 30, 2024		18,100		$	18	$	584,896	$	336,741	$	921,655

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

7

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Six Months Ended June 30, 2025 and 2024

(Amounts in Thousands)

(Unaudited)

	For the Six Months Ended
	June 30,
	2025			2024
Cash flows from operating activities:
Net income	$	43,280		$	33,909
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions:
Depreciation and amortization		7,856			6,870
Deferred income taxes		467			264
Stock-based compensation		7,590			5,474
Amortization of debt issuance costs under the credit facility		638			430
Provision for credit losses		681			486
Gain on disposal of assets		(8	)		(5	)
Loss on termination of operating leases		19			10
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		(15,936	)		5,362
Prepaid expenses and other current assets		2,856			7,127
Government stimulus advances		(3,312	)		7,235
Accounts payable		(12,844	)		(6,333	)
Accrued payroll		6,446			(1,449	)
Accrued expenses and other long-term liabilities		3,745			(1,889	)
Net cash provided by operating activities		41,478			57,491
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired		(3,350	)		(400	)
Purchases of property and equipment		(3,136	)		(2,421	)
Proceeds received from disposal of assets		18			19
Proceeds received from previous acquisition		2,937			—
Proceeds received from divestiture of business		3,848			4,600
Net cash used in investing activities		317			1,798
Cash flows from financing activities:
Payments on revolver — credit facility		(50,000	)		(126,353	)
Payments for debt issuance costs under the credit facility		(22	)		—
Proceeds from Public offering		—			175,578
Cash received from exercise of stock options		492			—
Net cash (used in) provided by financing activities		(49,530	)		49,225
Net change in cash		(7,735	)		108,514
Cash, at beginning of period		98,911			64,791
Cash, at end of period	$	91,176		$	173,305
Supplemental disclosures of cash flow information:
Cash paid for interest	$	7,019		$	4,491
Cash paid for income taxes		4,861			13,986

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

8

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us”, or “our”) operate as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill, or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The Company’s payors include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals.

Basis of Presentation

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of  December 31, 2024 has been derived from the Company’s audited financial statements for the year ended  December 31, 2024 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended  December 31, 2024 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein.

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

Principles of Consolidation

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

2. Summary of Significant Accounting Policies

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles and business combinations, and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.

9

 

Computation of Weighted Average Shares

The following table sets forth the computation of basic and diluted common shares:

	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	(Amounts in thousands)				(Amounts in thousands)
	2025		2024		2025		2024
Weighted average number of shares outstanding for basic per share calculation		18,045		16,177		18,011		16,120
Effect of dilutive potential shares:
Stock options		219		251		221		239
Restricted stock awards		68		70		108		90
Adjusted weighted average shares for diluted per share calculation		18,332		16,498		18,340		16,449
Anti-dilutive shares:
Stock options		—		19		—		42
Restricted stock awards		9		8		9		8

Recently Adopted Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Improvements to Reportable Segment Disclosures, which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require, among other things, disclosure of significant segment expenses that are regularly provided to an entity’s chief operating decision maker (“CODM”) and a description of other segment items (the difference between segment revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss) by reportable segment, as well as disclosure of the title and position of the CODM, and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The ASU was adopted in connection with the Company's most recent Annual Report on Form 10-K, which included significant segment expenses reviewed by the Company’s CODM, but did not have a material impact on the Company’s results of operations, financial position, or cash flows.

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, may be applied on a prospective basis with the option to apply the standard retrospectively, and allows for early adoption. These requirements are not expected to have a material impact on the Company’s financial statements and will expand income tax disclosures.

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which intends to provide investors more detailed disclosures around specific types of expenses. The new disclosures require certain details for expenses presented on the face of the Consolidated Statements of Operations as well as selling expenses to be presented in the notes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. The Company is currently assessing the impact and timing of adopting the updated provisions.

10

 

3. Divestiture

Effective May 20, 2024, the Company entered into a definitive asset purchase agreement to sell all of the Company’s New York operations for a purchase price of up to $23.0 million in cash, subject to certain adjustments, including adjustments for future operating requirements (the “New York Asset Sale”). The purchase price included 50% cash consideration, paid out as an initial payment of $4.6 million and $6.9 million paid pro rata as a deferred payment as caregivers are transferred, and 50% in the form of contingent consideration for the Company’s New York Consumer Directed Personal Assistance Program (“CDPAP”) business. The Company entered into a consulting agreement with the purchaser effective May 20, 2024, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coordination of the transfer of clients and caregivers occurs, and the change of control takes place. The Company determined that the consulting agreement gave it the ability to control the business until October 2024, when the Company determined that it no longer controlled the business as it transferred more than 50% of the clients and caregivers and therefore qualified for sale consideration of the New York Asset Sale. As a result, the Company deconsolidated the results of its New York operations and recorded a gain on divestiture of $3.7 million during the year ended December 31, 2024. The gain was reflected within general and administrative expenses on the consolidated statement of operations.

In connection with this transaction, the Company ceased operations in New York. During the six months ended June 30, 2025, the Company recorded deferred payments of $3.8 million with the remaining $2.3 million due from the purchaser reflected within prepaid expenses and other current assets on the condensed consolidated balance sheets as of June 30, 2025. No amount was recorded related to the CDPAP business contingent consideration.

The New York Asset Sale did not qualify as a discontinued operation because it did not represent a strategic shift that has or will have a major effect on the Company’s operation or financial results.

Goodwill and intangible assets of $2.9 million and $4.2 million, respectively, were derecognized in connection with the divestiture. The carrying amounts of the assets and liabilities associated with the New York personal care operations included in our Consolidated Balance Sheets as of June 30, 2025 were as follows (amounts in thousands):

	June 30, 2025
Assets
Current assets
Accounts receivable, net of allowances	$	—
Prepaid expenses and other current assets		11
Total current assets		11
Property and equipment, net of accumulated depreciation and amortization		—
Other assets
Goodwill		—
Intangibles, net of accumulated amortization		—
Operating lease assets, net		2,910
Total other assets		2,910
Total assets	$	2,921
Liabilities
Current liabilities
Accounts payable	$	1,064
Accrued payroll		8
Accrued expenses		599
Operating lease liabilities, current portion		642
Total current liabilities		2,313
Long-term liabilities
Operating lease liabilities, long-term portion		2,187
Total liabilities	$	4,500

11

 

4. Leases

Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:

	June 30, 2025		December 31, 2024
	(Amounts in Thousands)
Operating lease assets, net	$	45,965	$	47,348
Short-term operating lease liabilities		12,969		12,800
Long-term operating lease liabilities		40,223		41,883
Total operating lease liabilities	$	53,192	$	54,683

Lease Costs

Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

	For the Three Months Ended June 30,					For the Six Months Ended June 30,
	(Amounts in Thousands)					(Amounts in Thousands)
	2025		2024			2025			2024
Operating lease costs	$	3,651	$	3,373		$	7,308		$	6,669
Short-term lease costs		271		179			555			380
Total lease costs		3,922		3,552			7,863			7,049
Less: sublease income		—		(491	)		(226	)		(1,089	)
Total lease costs, net	$	3,922	$	3,061		$	7,637		$	5,960

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates were as follows:

	June 30, 2025			December 31, 2024
Operating leases:
Weighted average remaining lease term		5.37			5.48
Weighted average discount rate		6.32	%		6.20	%

12

 

Maturity of Lease Liabilities

Remaining operating lease payments as of  June 30, 2025 were as follows:

	Operating Leases
	(Amounts in Thousands)
Due in the 12-month period ended June 30,
2026	$	15,739
2027		12,746
2028		9,459
2029		6,946
2030		6,200
Thereafter		12,311
Total future minimum rental commitments		63,401
Less: Imputed interest		(10,209	)
Total lease liabilities	$	53,192

Supplemental Cash Flows Information

	For the Six Months Ended June 30,
	(Amounts in Thousands)
	2025		2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	8,368	$	7,224
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	5,158	$	4,509

5. Goodwill and Intangible Assets

A summary of the goodwill by segment and related adjustments is provided below:

						Home
	Hospice		Personal Care			Health			Total
	(Amounts in Thousands)
Goodwill as of December 31, 2024	$	432,840	$	442,526		$	95,192		$	970,558
Additions for acquisitions		—		3,350			—			3,350
Adjustments to previously recorded goodwill		26		(3,768	)		(342	)		(4,084	)
Goodwill as of June 30, 2025	$	432,866	$	442,108		$	94,850		$	969,824

On January 1, 2025, the Company completed its acquisition of its Jacksonville affiliate for approximately $0.8 million (the “Jacksonville Acquisition”), with funding provided by available cash. With the Jacksonville Acquisition, the Company expanded its personal care segment in Florida and recorded goodwill of $0.8 million.

On March 1, 2025, the Company completed its acquisition of the assets of Great Lakes Home Care Unlimited, LLC for $2.6 million (the “Great Lakes Acquisition”), with funding provided by available cash. With the Great Lakes Acquisition, the Company expanded its personal care segment in Michigan and recognized goodwill in its personal care segment of $2.6 million.

During the three and six months ended June 30, 2025, the Company recorded $2.5 million and $4.1 million, respectively, related to measurement period adjustments to previously recorded goodwill including $2.9 million of proceeds received in connection with the Gentiva Acquisition. 

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements, and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from one to twenty years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from three to fifteen years.

13

 

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following:

		June 30, 2025							December 31, 2024
		(Amounts in Thousands)							(Amounts in Thousands)
	Estimated Useful	Gross		Accumulated			Net		Gross		Accumulated			Net
	Life (years)	carrying value		amortization			carrying value		carrying value		amortization			carrying value
Customer and referral relationships	3 - 15	$	34,201	$	(33,461	)	$	740	$	34,201	$	(33,255	)	$	946
Trade names and trademarks	1 - 20		59,366		(24,217	)		35,149		59,366		(21,900	)		37,466
Non-competition agreement	3 - 5		6,728		(6,476	)		252		6,728		(6,263	)		465
State Licenses	6 - 10		24,981		(2,494	)		22,487		24,981		(1,243	)		23,738
State Licenses	Indefinite		47,028		—			47,028		47,028		—			47,028
Total intangible assets		$	172,304	$	(66,648	)	$	105,656	$	172,304	$	(62,661	)	$	109,643

Amortization expense related to the intangible assets was $2.0 million and $4.0 million for the three and six months ended June 30, 2025, respectively, and $1.8 million and $3.6 million for the three and six months ended June 30, 2024, respectively. The weighted average remaining useful lives of identifiable intangible assets as of  June 30, 2025 was 9.45 years.

6. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consisted of the following:

	June 30, 2025		December 31, 2024
	(Amounts in Thousands)
Income tax receivable	$	3,232	$	11,568
Prepaid payroll		12,066		8,716
Prepaid workers' compensation and liability insurance		1,272		4,254
Prepaid licensing fees		5,962		5,414
Workers' compensation insurance receivable		767		810
Other (1)		8,472		7,829
Total prepaid expenses and other current assets	$	31,771	$	38,591

(1) Included $2.3 million and $6.1 million related to the New York Asset Sale deferred payments as of June 30, 2025 and December 31, 2024, respectively.

Accrued expenses consisted of the following:

	June 30, 2025		December 31, 2024
	(Amounts in Thousands)
Accrued health benefits	$	6,342	$	6,637
Accrued professional fees		7,117		5,368
Accrued payroll and other taxes		5,055		4,516
Other		14,540		12,438
Total accrued expenses	$	33,054	$	28,959

14

 

7. ARPA Spending Plans

To mitigate the fiscal effects of the COVID-19 public health emergency, the American Rescue Plan Act of 2021 (“ARPA”) provided for a 10-percentage point increase in federal matching funds for Medicaid home and community-based services (“HCBS”) from April 1, 2021, through March 31, 2022, provided the states satisfied certain conditions. States were generally permitted to use the state funds equivalent to the additional federal funds through March 31, 2025, but CMS granted extensions to several states, permitting some state spending plans to continue until as late as mid-2026. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021.

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses.

During the three and six months ended June 30, 2025, the Company did not receive additional state funding provided by the ARPA. Of the total state funding received by the Company pursuant to the ARPA through June 30, 2025, the Company utilized $0.8 million and $3.3 million during the three and six months ended June 30, 2025, respectively, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of June 30, 2025, the deferred portion of ARPA funding of $7.9 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

8. Long-Term Debt

Long-term debt consisted of the following:

	June 30, 2025			December 31, 2024
	(Amounts in Thousands)
Revolving loan under the credit facility	$	173,000		$	223,000
Less unamortized issuance costs		(3,941	)		(4,557	)
Long-term debt	$	169,059		$	218,443

Amended and Restated Senior Secured Credit Facility

On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of September 12, 2019, as further amended by the Second Amendment to Amended and Restated Credit Agreement, dated as of July 30, 2021, as further amended by the Third Amendment to Amended and Restated Credit Agreement, dated as of April 26, 2023, and as further amended by the Fourth Amendment to Amended and Restated Credit Agreement, dated as of October 22, 2024 (as described below, the “Fourth Amendment”) (as amended, the “Credit Agreement”, as used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement). The credit facility consists of a $650.0 million revolving credit facility and a $150.0 million incremental loan facility, which incremental loan facility may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is July 30, 2028.

On October 22, 2024, the Company entered into the Fourth Amendment to, among other things, (a) increase the Company’s revolving credit facility to an aggregate amount of $650.0 million, (b) increase the Company’s incremental loan facility to an aggregate amount of $150.0 million, and (c) extend the maturity date of the credit facility from July 30, 2026 to July 30, 2028.

15

 

Interest on the credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50%, and (c) the sum of Term Secured Overnight Financing Rate (“SOFR”) (as published by the CME Group Benchmark Administrative Limited) for an interest period of one month for such applicable day (not to be less than 0.00%), plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the rate per annum equal to the sum of Term SOFR (as published by the CME Group Benchmark Administrative Limited) for the applicable interest period (not to be less than 0.00%). Swing loans may not be SOFR loans.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions, and dispositions of assets. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters.

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility.

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property, and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement). The Credit Agreement also contains restrictions on guarantees, indebtedness, liens, investments, and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $10.0 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement) thresholds, restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business.

During the six months ended June 30, 2025, the Company did not draw on its credit facility and repaid $50.0 million under its revolving credit facility.

As of June 30, 2025, the Company had a total of $173.0 million of revolving loans, with an interest rate of 6.07%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $8.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $635.6 million of capacity and $454.6 million available for borrowing under its credit facility. As of December 31, 2024, the Company had a total of $223.0 million of revolving loans, with an interest rate of 6.34%, outstanding on its credit facility.

As of June 30, 2025, the Company was in compliance with all financial covenants under the Credit Agreement.

16

 

9. Income Taxes

The effective income tax rates were 26.4% and 26.3% for the three months ended June 30, 2025 and 2024, respectively. The effective income tax rates were 24.0% and 26.0% for the six months ended June 30, 2025 and 2024, respectively.

For the three months ended June 30, 2025, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation and an excess tax expense, partially offset by the use of federal employment tax credits. For both the three months ended June 30, 2025 and 2024, the effective tax rates were inclusive of an excess tax expense and tax benefit of 0.1%, respectively. The excess tax expense and tax benefit are discrete items, related to the vesting of equity shares, which requires the Company to recognize the expense or benefit fully in the period. An excess tax expense results if the Company’s cumulative costs of the award recognized exceed the income tax deduction, whereas an excess tax benefit results if the Company’s cumulative costs of the award recognized are less than the income tax deduction.

10. Commitments and Contingencies

Legal Proceedings

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business.

It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

11. Segment Information

Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s CODM. The Company identifies its Chief Executive Officer and Chief Operating Officer together as CODMs to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy.

The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

The CODMs do not review disaggregated assets by segment. The measure of segment assets is reported on the balance sheet as total consolidated assets.

17

 

The tables below set forth information about the Company’s reportable segments, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Unaudited Condensed Consolidated Financial Statements.

	For the Three Months Ended June 30, 2025
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	269,183	$	62,212	$	18,048	$	349,443
Direct service personnel		192,868		26,177		9,451		228,496
General and administrative salaries, wages and benefits		18,407		11,448		3,029		32,884
Other segment items 1		6,268		9,765		1,186		17,219
Segment operating income		51,640		14,822		4,382		70,844
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								34,044
Depreciation and amortization								3,913
Interest income								(583	)
Interest expense								3,525
Income before income taxes							$	29,945

(1) Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

	For the Three Months Ended June 30, 2024
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	212,817	$	56,030	$	18,075	$	286,922
Direct service personnel		152,442		23,465		10,830		186,737
General and administrative salaries, wages and benefits		11,939		9,965		3,676		25,580
Other segment items 1		5,347		9,766		1,345		16,458
Segment operating income		43,089		12,834		2,224		58,147
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								28,565
Depreciation and amortization								3,401
Interest income								(474	)
Interest expense								2,114
Income before income taxes							$	24,541

(1) Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

18

 

	For the Six Months Ended June 30, 2025
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	527,469	$	123,649	$	36,033	$	687,151
Direct service personnel		379,518		52,382		19,864		451,764
General and administrative salaries, wages and benefits		36,647		22,427		6,308		65,382
Other segment items 1		12,073		19,401		2,465		33,939
Segment operating income		99,231		29,439		7,396		136,066
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								64,809
Depreciation and amortization								7,856
Interest income								(1,085	)
Interest expense								7,543
Income before income taxes							$	56,943

(1) Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense

	For the Six Months Ended June 30, 2024
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	420,820	$	111,893	$	34,955	$	567,668
Direct service personnel		304,515		46,789		21,453		372,757
General and administrative salaries, wages and benefits		23,099		20,043		7,339		50,481
Other segment items 1		10,095		18,770		2,662		31,527
Segment operating income		83,111		26,291		3,501		112,903
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								56,207
Depreciation and amortization								6,870
Interest income								(897	)
Interest expense								4,872
Income before income taxes							$	45,851

(1) Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense

19

 

12. Significant Payors

The Company’s revenue by payor type was as follows:

Personal Care Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
State, local and other governmental programs	$	138,506		51.4	%	$	113,002		53.1	%	$	271,410		51.4	%	$	220,756		52.5	%
Managed care organizations		121,900		45.3			94,135		44.2			238,907		45.3			188,411		44.8
Private pay		7,292		2.7			3,689		1.7			14,268		2.7			7,595		1.8
Commercial insurance		1,334		0.5			1,467		0.7			2,494		0.5			2,953		0.7
Other		151		0.1			524		0.3			390		0.1			1,105		0.2
Total personal care segment net service revenues	$	269,183		100.0	%	$	212,817		100.0	%	$	527,469		100.0	%	$	420,820		100.0	%

Hospice Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Medicare	$	57,846		93.0	%	$	51,122		91.2	%	$	114,638		92.7	%	$	101,774		91.0	%
Commercial insurance		1,997		3.2			2,844		5.1			4,375		3.5			5,978		5.3
Managed care organizations		2,001		3.2			1,880		3.4			4,029		3.3			3,697		3.3
Other		368		0.6			184		0.3			607		0.5			444		0.4
Total hospice segment net service revenues	$	62,212		100.0	%	$	56,030		100.0	%	$	123,649		100.0	%	$	111,893		100.0	%

20

 

Home Health Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Medicare	$	12,517		69.4	%	$	12,517		69.3	%	$	25,094		69.7	%	$	24,180		69.2	%
Managed care organizations		4,264		23.6			4,676		25.9			8,072		22.4			9,076		26.0
State, local and other governmental programs (excluding Medicare)		796		4.4			44		0.2			1,884		5.2			70		0.2
Other		471		2.6			838		4.6			983		2.7			1,629		4.6
Total home health segment net service revenues	$	18,048		100.0	%	$	18,075		100.0	%	$	36,033		100.0	%	$	34,955		100.0	%

The Company derives a significant amount of its revenue from its operations in Illinois, New Mexico, Ohio, Tennessee, and Texas. The percentages of segment revenue for each of these significant states and New York for the three and six months ended June 30, 2025 and 2024, respectively, were as follows:

Personal Care Segment	For the Three Months Ended June 30,											For the Six Months Ended June 30,
	2025						2024					2025					2024
				% of Segment					% of Segment					% of Segment					% of Segment
	Amount			Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)			Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Illinois	$	115,226			42.8	%	$	110,774		52.1	%	$	226,640		43.0	%	$	218,349		51.9	%
New Mexico		28,987			10.8			28,644		13.5			57,292		10.9			57,611		13.7
New York(1)		(59	)		—			23,299		10.9			214		—			46,833		11.1
Texas		52,464			19.5			—		—			102,324		19.4			—		—
All other states		72,565			26.9			50,100		23.5			140,999		26.7			98,027		23.3
Total personal care segment net service revenues	$	269,183			100.0	%	$	212,817		100.0	%	$	527,469		100.0	%	$	420,820		100.0	%

(1) As a result of changes and uncertainty in New York regarding the CDPAP, the Company determined that its New York personal care operations no longer fit its growth strategy and is divesting these operations. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture.

21

 

Hospice Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Ohio	$	23,204		37.3	%	$	20,633		36.8	%	$	46,391		37.5	%	$	40,869		36.5	%
Illinois		14,419		23.2			13,003		23.2			28,983		23.4			25,255		22.6
New Mexico		8,184		13.2			6,895		12.3			16,097		13.0			14,410		12.9
All other states		16,405		26.3			15,499		27.7			32,178		26.1			31,359		28.0
Total hospice segment net service revenues	$	62,212		100.0	%	$	56,030		100.0	%	$	123,649		100.0	%	$	111,893		100.0	%

Home Health Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
New Mexico	$	8,737		48.4	%	$	8,300		45.9	%	$	17,292		48.0	%	$	16,077		46.0	%
Illinois		1,989		11.0			3,042		16.8			3,921		10.9			5,984		17.1
Tennessee		7,322		40.6			6,733		37.3			14,820		41.1			12,894		36.9
Total home health segment net service revenues	$	18,048		100.0	%	$	18,075		100.0	%	$	36,033		100.0	%	$	34,955		100.0	%

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state, and local governmental agencies. The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 33.0% and 38.6% of our net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 33.0% and 38.5% of our net service revenues for the six months ended June 30, 2025 and 2024, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 18.6% and 21.1% of the Company’s net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 18.6% and 20.9% of the Company’s net service revenues for the six months ended June 30, 2025 and 2024, respectively.

The related receivables due from the Illinois Department on Aging represented 19.0% and 21.7% of the Company’s net accounts receivable at  June 30, 2025 and December 31, 2024, respectively.

13. Subsequent Events

On August 1, 2025, the Company completed the acquisition of Helping Hands Home Care Service, Inc., a Pennsylvania corporation (“Helping Hands”), for approximately $21.3 million. The purchase was funded through the Company’s revolving credit facility and available cash. With the purchase of Helping Hands, the Company expanded its services within its personal care segment and entered the hospice and home health markets in Pennsylvania. The initial accounting is not yet complete, and therefore the related business combination disclosures have not been presented as the Company is currently in the process of valuing the assets acquired and liabilities assumed in the transaction.

On July 4, 2025, H.R. 1, commonly known as the “One Big Beautiful Bill Act” (the “OBBBA”), was enacted into law. The OBBBA includes several provisions, including the permanent extension of several business tax benefits originally introduced under the 2017 Tax Cuts and Jobs Act. The Company is currently evaluating the impact of the legislation on its condensed consolidated financial statements.

22

 

ITEM 2.       MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements about our business and operations. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words like “believes,” “belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,” “might,” “would,” “should,” and similar expressions are intended to be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the impact of macroeconomic conditions, including significant global inflation and interest rates, legislative and political developments, including any hold on or cancellation of congressionally authorized spending or interruptions in the distribution of government funds, trade policies and tensions, including changes in, or the imposition of, tariffs and/or trade barriers and the economic impacts, volatility and uncertainty resulting therefrom, and the potential adverse effects of current conditions; business disruptions due to inclement weather, natural disasters, acts of terrorism, military conflicts, pandemics, civil insurrection or social unrest; changes in operational and reimbursement processes and payment structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations’ policies and payment rates, and the timeliness of reimbursements received under government programs; the implementation of new, and possible changes to, existing, federal and state laws or regulations, or our failure to comply with such laws or regulations or comply on a timely basis; the impact of decisions of the U.S. Supreme Court regarding the actions of federal agencies; changes in presidential administrations; changes in the structure and administration of, and funding for, federal and state agencies and programs; competition in the healthcare industry; the geographical concentration of our operations; changes in the case mix of consumers and payment methodologies; operational changes resulting from the assumption by managed care organizations of responsibility for managing and paying for our services to consumers; the nature and success of future financial and/or delivery system reforms; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new referral sources; our ability to renew significant agreements or groups of agreements; our ability to attract and retain qualified personnel; federal, state and city minimum wage pressure, including any failure of any governmental entity to enact a minimum wage offset and/or the timing of any such enactment; changes in payments and covered services due to overall economic conditions and deficit reduction measures by federal and state governments, and our expectations regarding these changes; cost containment initiatives undertaken by federal and state governmental and other third-party payors; our ability to access financing through the capital and credit markets; our ability to meet debt service requirements and comply with covenants in debt agreements; our ability to integrate and manage our information systems; any security breaches, cyber-attacks, loss of data, or cybersecurity threats or incidents, and any actual or perceived failures to comply with legal requirements related to the privacy of confidential consumer data and other sensitive information; the size and growth of the markets for our services, including our expectations regarding the markets for our services; eligibility standards and coverage limits imposed through legislation or by governmental agencies or other third-party payors; the potential for litigation, audits, and investigations; discretionary determinations by government officials; our ability to successfully implement our business model to grow our business; our ability to continue identifying, pursuing, consummating, and integrating acquisition opportunities and expanding into new geographic markets; the impact of acquisitions and dispositions on our business, including the potential inability to realize the benefits of potential acquisitions; the effectiveness, quality, and cost of our services; our ability to successfully execute our growth strategy; changes in tax rates;  and various other matters, many of which are beyond our control. In addition, these forward-looking statements are subject to the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2024, filed with the SEC on February 25, 2025. You should carefully review all of these factors. Moreover, our business may be materially adversely affected by factors that are not currently known to us, by factors that we currently consider immaterial or by factors that are not specific to us, such as general economic conditions. These forward-looking statements were based on information, plans, and estimates at the date of this report, and we assume no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes, except as may be required by law.

Overview

We are a home care services provider operating three segments: personal care, hospice, and home health. Our services are principally provided in-home under agreements with federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals. Our consumers are predominantly “dual eligible,” meaning they are eligible to receive both Medicare and Medicaid benefits. Managed care organizations accounted for 35.6% and 34.2% of our net service revenues during the three months ended June 30, 2025 and 2024, respectively, and 35.6% and 34.2% of our net service revenues during the six months ended June 30, 2025 and 2024, respectively.

23

A summary of certain consolidated financial results is provided in the table below.

	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	2025		2024		2025		2024
Net service revenues by segment:	(Amounts in Thousands)				(Amounts in Thousands)
Personal care	$	269,183	$	212,817	$	527,469	$	420,820
Hospice		62,212		56,030		123,649		111,893
Home health		18,048		18,075		36,033		34,955
Total net service revenue	$	349,443	$	286,922	$	687,151	$	567,668
Net income	$	22,052	$	18,079	$	43,280	$	33,909

As of June 30, 2025, we provided our services in 23 states through 260 offices. We served approximately 78,000 and 70,000 discrete individuals, respectively, during the six months ended June 30, 2025 and 2024. Our personal care segment also includes staffing services, with clients including assisted living facilities, nursing homes, and hospice facilities.

Acquisitions

In addition to our organic growth, we have grown through acquisitions that have expanded our presence in current markets, with the goal of having all three levels of in-home care in our markets or facilitating our entry into new markets where in-home care has been moving to managed care organizations or that present other strategic opportunities.

On March 9, 2024, we completed our acquisition of the operations of Upstate Home Care Solutions (“Upstate”) for $0.4 million, with funding provided by available cash. With the purchase of Upstate, the Company expanded its personal care segment in South Carolina.

On December 2, 2024, we completed the acquisition of the personal care business of Curo Health Services, LLC, a Delaware limited liability company that does business as Gentiva, consisting of certain equity interests and assets and liabilities (collectively, the “Gentiva Acquisition”) for approximately $350.6 million, with funding primarily provided by drawing on the Company’s revolving credit facility and a portion of the net proceeds of the Company’s public offering of common stock (the “Public Offering”). With the Gentiva Acquisition, the Company expanded its services within its personal care segment in Arizona, Arkansas, California, and North Carolina, and entered the market in Missouri and Texas. The home health segment also was expanded in Tennessee.

On January 1, 2025, the Company completed the Jacksonville Acquisition for approximately $0.8 million, with funding provided by available cash. With the Jacksonville Acquisition, the Company expanded its personal care segment in Florida and recorded goodwill of $0.8 million.

On March 1, 2025, the Company completed the Great Lakes Acquisition for $2.6 million, with funding provided by available cash. With the Great Lakes Acquisition, the Company expanded its personal care segment in Michigan and recognized goodwill in its personal care segment of $2.6 million.

New York Asset Sale

Effective May 20, 2024, we entered into the New York Asset Sale. The Company entered into a consulting agreement with the purchaser, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coordination of the transfer of clients and caregivers occurs, and the change of control takes place. In connection with this transaction, the Company ceased operations in New York. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divesture, for additional details regarding our divestiture.

24

Recruiting

As the labor market continues to be tight and unemployment remains at low levels, the competition for new caregivers, including skilled healthcare staff, and support staff continues to be significant. In addition, the United States economy continues to experience inflationary pressures. To the extent that we continue to experience a shortage of caregivers, it may hinder our ability to fully meet the continuing demand for both our non-clinical and clinical services.

Revenue by Payor and Significant States

Our payors are principally federal, state, and local governmental agencies and managed care organizations. The federal, state, and local programs under which the agencies operate are subject to legislative and budgetary changes and other risks that can influence reimbursement rates. We are experiencing a transition of business from government payors to managed care organizations, which we believe aligns with our emphasis on coordinated care and the reduction of the need for acute care.

Our revenue by payor and significant states by segment were as follows:

Personal Care Segment	For the Three Months Ended June 30,											For the Six Months Ended June 30,
	2025						2024					2025					2024
				% of Segment					% of Segment					% of Segment					% of Segment
	Amount			Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)			Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
State, local and other governmental programs	$	138,506			51.4	%	$	113,002		53.1	%	$	271,410		51.4	%	$	220,756		52.5	%
Managed care organizations		121,900			45.3			94,135		44.2			238,907		45.3			188,411		44.8
Private pay		7,292			2.7			3,689		1.7			14,268		2.7			7,595		1.8
Commercial insurance		1,334			0.5			1,467		0.7			2,494		0.5			2,953		0.7
Other		151			0.1			524		0.3			390		0.1			1,105		0.2
Total personal care segment net service revenues	$	269,183			100.0	%	$	212,817		100.0	%	$	527,469		100.0	%	$	420,820		100.0	%
Illinois		115,226			42.8	%		110,774		52.1	%		226,640		43.0	%		218,349		51.9	%
New Mexico		28,987			10.8			28,644		13.5			57,292		10.9			57,611		13.7
New York		(59	)		—			23,299		10.9			214		—			46,833		11.1
Texas		52,464			19.5			—		—			102,324		19.4			—		—
All other states		72,565			26.9			50,100		23.5			140,999		26.7			98,027		23.3
Total personal care segment net service revenues	$	269,183			100.0	%	$	212,817		100.0	%	$	527,469		100.0	%	$	420,820		100.0	%

25

Hospice Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Medicare	$	57,846		93.0	%	$	51,122		91.2	%	$	114,638		92.7	%	$	101,774		91.0	%
Commercial insurance		1,997		3.2			2,844		5.1			4,375		3.5			5,978		5.3
Managed care organizations		2,001		3.2			1,880		3.4			4,029		3.3			3,697		3.3
Other		368		0.6			184		0.3			607		0.5			444		0.4
Total hospice segment net service revenues	$	62,212		100.0	%	$	56,030		100.0	%	$	123,649		100.0	%	$	111,893		100.0	%
Ohio	$	23,204		37.3	%	$	20,633		36.8	%	$	46,391		37.5	%	$	40,869		36.5	%
Illinois		14,419		23.2			13,003		23.2			28,983		23.4			25,255		22.6
New Mexico		8,184		13.2			6,895		12.3			16,097		13.0			14,410		12.9
All other states		16,405		26.3			15,499		27.7			32,178		26.1			31,359		28.0
Total hospice segment net service revenues	$	62,212		100.0	%	$	56,030		100.0	%	$	123,649		100.0	%	$	111,893		100.0	%

Home Health Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Medicare	$	12,517		69.4	%	$	12,517		69.3	%	$	25,094		69.7	%	$	24,180		69.2	%
Managed care organizations		4,264		23.6			4,676		25.9			8,072		22.4			9,076		26.0
State, local and other governmental programs (excluding Medicare)		796		4.4			44		0.2			1,884		5.2			70		0.2
Other		471		2.6			838		4.6			983		2.7			1,629		4.6
Total home health segment net service revenues	$	18,048		100.0	%	$	18,075		100.0	%	$	36,033		100.0	%	$	34,955		100.0	%
New Mexico	$	8,737		48.4	%	$	8,300		45.9	%	$	17,292		48.0	%	$	16,077		46.0	%
Illinois		1,989		11.0			3,042		16.8			3,921		10.9			5,984		17.1
Tennessee		7,322		40.6			6,733		37.3			14,820		41.1			12,894		36.9
Total home health segment net service revenues	$	18,048		100.0	%	$	18,075		100.0	%	$	36,033		100.0	%	$	34,955		100.0	%

The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 33.0% and 38.6% of our net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 33.0% and 38.5% of our net service revenues for the six months ended June 30, 2025 and 2024, respectively.

A significant amount of our net service revenues are derived from one payor, the Illinois Department on Aging, the largest payor program for our Illinois personal care operations, which accounted for 18.6% and 21.1% of our net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 18.6% and 20.9% of our net service revenues for the six months ended June 30, 2025 and 2024, respectively.

26

Changes in Illinois Reimbursement

The Illinois Medicaid omnibus legislation passed in June 2023 included an increase in hourly rates for in-home care services to $28.07, which took effect on January 1, 2024 and required a minimum wage rate of $17.00 per hour. CMS approved an amendment to the Illinois HCBS Waiver for Persons Who are Elderly, which included the rate increase for in-home care services to $28.07, effective January 1, 2024.

The Illinois fiscal year 2025 budget included an increase in hourly rates for in-home care services to $29.63, effective January 1, 2025, and required a minimum wage of $18.00 per hour for direct service workers. CMS approved an amendment to Illinois’ Persons Who are Elderly waiver program that included this rate increase, effective January 1, 2025.

The Illinois fiscal year 2026 budget includes an increase in hourly rates for in-home care services to $30.80, to take effect January 1, 2026, subject to standard federal approval. This rate sustains a minimum wage of $18.75 per hour for direct service workers.

The City of Chicago requires the Chicago minimum wage to be adjusted annually based on increases in the Consumer Price Index (“CPI”), subject to a cap and other requirements. Effective July 1, 2025, the rate was adjusted to $16.60 based on the increase in the CPI.

Our business will benefit from the rate increases noted above as planned for 2025, but there is no assurance that there will be additional rate increases in Illinois for fiscal years beyond fiscal year 2025 to offset increases to minimum wage, and our financial performance will be adversely impacted for any periods in which an additional offsetting reimbursement rate increase is not in effect.

Changes in Texas Reimbursement

The Texas fiscal year 2026 budget includes an increase in hourly rates to $17.13 for in-home care services effective September 1, 2025, subject to standard federal approval.

Impact of Changes in Medicare and Medicaid Reimbursement

Hospice

Hospice services provided to Medicare beneficiaries are paid under the Medicare Hospice Prospective Payment System, under which CMS sets a daily rate for each day a patient is enrolled in the hospice benefit. The daily rate depends on the level of care provided to a patient (routine home care, continuous home care, inpatient respite care, or general inpatient care). Daily rates are adjusted for factors such as area wage levels. CMS updates hospice payment rates each federal fiscal year. Effective October 1, 2024, CMS increased hospice payment rates by 2.9%. This reflects a 3.4% market basket increase and a negative 0.5 percentage point productivity adjustment. Hospices that do not satisfy quality reporting requirements are subject to a 4-percentage point reduction to the market basket update.

Overall payments made by Medicare to each hospice provider number are subject to an inpatient cap and an aggregate cap. The inpatient cap limits the number of days of inpatient care for which Medicare will pay to no more than 20% of total patient care days. Days in excess of the limitation are paid at the routine home care rate. The aggregate cap limits the total Medicare reimbursement that a hospice may receive in a cap year (typically the federal fiscal year) based on an annual per-beneficiary cap amount, which is set each federal fiscal year, and the number of Medicare patients served. The per-beneficiary cap amount was updated to $34,465.34 for federal fiscal year 2025. If a hospice’s Medicare payments exceed its inpatient or aggregate caps, it must repay Medicare the excess amount.

Home Health

Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System (“HHPPS”), which uses national, standardized 30-day period payment rates for periods of care that meet a certain threshold of home health visits (periods of care that do not meet the visit threshold are paid a per-visit payment rate for the discipline providing care). Although payment is made for each 30-day period, the HHPPS permits continuous 60-day certification periods through which beneficiaries are verified as eligible for the home health benefit. The daily home health payment rate is adjusted for case-mix and area wage levels. CMS uses the Patient-Driven Groupings Model (“PDGM”) as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics and their resource needs. An outlier adjustment may be paid for periods of care where costs exceed a specific threshold amount.

27

CMS updates the HHPPS payment rates each calendar year. For calendar year 2025, CMS estimates that Medicare payments to home health agencies will increase by 0.5%. This is based on a home health payment update percentage of 2.7%, which reflects a 3.2% market basket update, reduced by a productivity adjustment of 0.5 percentage points, and an estimated 1.8% decrease associated with the transition to the PDGM, among other changes. Home health providers that do not comply with quality data reporting requirements are subject to a 2-percentage point reduction to their market basket update. In addition, Medicare requires home health agencies to submit a one-time Notice of Admission (“NOA”) for each patient that establishes that the beneficiary is under a Medicare home health period of care. Failure to submit the NOA within five calendar days from the start of care will result in a reduction to the 30-day period payment amount for each day from the start of care date until the date the NOA is submitted.

Under the nationwide Home Health Value-Based Purchasing (“HHVBP”) Model, home health agencies receive increases or decreases to their Medicare fee-for-service payments of up to 5% based on performance against specific quality measures relative to the performance of other home health providers. Data collected in each performance year will impact Medicare payments two years later.

In certain states, payment of claims may be impacted by the Review Choice Demonstration for Home Health Services, a program intended to identify and prevent fraud, reduce the number of Medicare appeals and improve provider compliance with Medicare program requirements. The program is currently limited to home health agencies in Illinois, Ohio, Oklahoma, North Carolina, Florida, and Texas. Providers in states subject to the Review Choice Demonstration for Home Health Services may initially select either pre-claim review or post-payment review. Home health agencies that maintain high compliance levels are eligible for additional options that may be less burdensome. This program has not had a material impact on our results of operations or financial position.

CMS Final Rule: “Ensuring Access to Medicaid Services”

In May 2024, CMS finalized a rule intended to improve access to services and quality of care for Medicaid beneficiaries across fee-for-service and managed care delivery systems. The final rule includes significant provisions related to HCBS, including the “80/20” or “payment adequacy” requirement, which will require states to ensure by mid-2030 that at least 80% of all Medicaid payments a provider receives for homemaker, home health aide, and personal care services, less certain excluded costs, under specified programs are spent on total compensation (including benefits) for direct care workers furnishing these services, rather than administrative overhead or profit, subject to limited exceptions. The final rule includes several other measures intended to promote transparency and enhance quality and access to services, including a variety of reporting requirements for states. Given the long implementation period and the likelihood of further changes as a result of litigation, administration and congressional changes, further rule-making and state changes in response to the final rule, it is premature to predict the ultimate impact of the final rule on our business.

Developments in Public Policy

The outcome of the 2024 federal election increased regulatory uncertainty and the potential for significant policy changes. President Trump has issued executive orders that impact or may impact the healthcare industry, including an order establishing a presidential advisory commission, the Department of Government Efficiency (“DOGE”), focused on restructuring and streamlining government agencies and reducing or eliminating regulations and federal government programs and other expenditures. In March 2025, the Department of Health and Human Services (“HHS”) announced a significant restructuring in accordance with the President’s DOGE Workforce Optimization Initiative. The restructuring will reduce the HHS workforce and consolidate divisions of HHS, including integrating some functions of the Administration for Community Living, which administers programs that support older adults, into other HHS agencies. HHS also announced a change in its policy on public participation in rulemaking that may negatively affect the ability of industry participants to receive advance notice of and offer feedback on some policy changes. In addition, recent actions by the presidential administration have resulted in holds on or cancellations of congressionally authorized spending as well as interruptions in the distribution of governmental funds.

28

Home care and other healthcare providers may be significantly impacted by changes to the Medicaid program, including changes resulting from legislation and administrative actions at the federal and state levels. Federal actions may impact funding for, or the structure of, the Medicaid program, including through changes to Medicaid waiver programs, and may shape provider reimbursement rates, eligibility and coverage policies, and other aspects of state Medicaid programs. For example, the OBBBA includes policy changes that are expected to eventually result in significant cuts to federal healthcare spending, including significant changes to the Medicaid program, if fully implemented as enacted. The OBBBA limits eligibility for Medicaid through work requirements for some populations, reduces federal Medicaid funding and expands cost-sharing obligations for certain enrollees. Among other changes, the law makes significant changes to Medicaid financing mechanisms, including restrictions on provider tax arrangements that are intended to reduce the federal matching funds received by state Medicaid programs. In addition, the OBBBA, if implemented as enacted, would require eligibility redeterminations at least every six months for individuals covered under Medicaid expansion, with state compliance required by December 31, 2026. The law also would eventually prohibit states from establishing new provider taxes or increasing rates of existing provider taxes while also limiting the structure of such taxes. Future Medicaid reform initiatives at the federal and state levels may result in further reductions to Medicaid expenditures and involve additional administrative changes. Reduced funding for Medicaid or other changes to Medicaid programs, including Medicaid waiver programs could put pressure on state budgets and result in reductions to Medicaid payments, scope of coverage and enrollment. Such reductions could, in turn, affect our reimbursements for services rendered. We expect the impact of the OBBBA on the home care business will be less significant than the impact on other healthcare businesses.

The federal deficit and other federal and state budgetary pressures affect government healthcare program expenditures, and we anticipate that these effects will continue. For example, the OBBBA is expected to decrease federal healthcare spending, particularly with respect to Medicaid, and is generally expected to have a significant impact on state budgets, which may result in state-level changes such as reductions to the scope of covered services or tax increases. In addition, the OBBBA increases the federal budget deficit in a manner that triggers a statutorily mandated sequestration under the Pay-As-You-Go Act of 2010. As a result, a Medicare spending reduction of up to 4% is required to take effect in early 2026, absent congressional action. These reductions would be in addition to the payment reductions required by the Budget Control Act of 2011 and subsequent legislation, which are currently set to continue through the first ten months of federal fiscal year 2032. It is possible that future deficit reduction legislation will impose additional spending reductions.

Components of our Statements of Income

Net Service Revenues

We generate net service revenues by providing our services directly to consumers and primarily on an hourly basis in our personal care segment, on a daily basis in our hospice segment, and on an episodic basis in our home health segment. We receive payment for providing such services from our private consumers and payors, including federal, state, and local governmental agencies, managed care organizations, and commercial insurers.

In our personal care segment, net service revenues are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate, which is either contractual or fixed by legislation, and are recognized at the time services are rendered. In our hospice segment, net service revenues are provided based on daily rates for each of the levels of care and are recognized as services are provided. In our home health segment, net service revenues are based on an episodic basis at a stated rate and recognized based on the number of days elapsed during a period of care within the reporting period. We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record revenues.

Cost of Service Revenues

We incur direct care wages, payroll taxes, and benefit-related costs in connection with providing our services. We also provide workers’ compensation and general liability coverage for our employees. Employees are also reimbursed for their travel time and related travel costs in certain instances.

General and Administrative Expenses

Our general and administrative expenses include our costs for operating our network of local agencies and our administrative offices. Our agency expenses consist of costs for supervisory personnel, our community care supervisors, and office administrative costs. Personnel costs include wages, payroll taxes, and employee benefits. Facility costs include rents, utilities, and postage, telephone, and office expenses. Our corporate and support center expenses include costs for accounting, information systems, human resources, billing and collections, contracting, marketing, and executive leadership. These expenses consist of compensation, including stock-based compensation, payroll taxes, employee benefits, legal, accounting and other professional fees, travel, general insurance, rents, provision for doubtful accounts, and related facility costs. Expenses related to streamlining our operations such as costs related to terminated employees, termination of professional services relationships, other contract termination costs, and asset write-offs are also included in general and administrative expenses.

Depreciation and Amortization Expenses

Depreciable assets consist principally of furniture and equipment, network administration and telephone equipment, and operating system software. Depreciable and leasehold assets are depreciated or amortized on a straight-line method over their useful lives or, if less and if applicable, their lease terms. We amortize our intangible assets with finite lives, consisting of customer and referral relationships, trade names, trademarks, and non-competition agreements, using straight line or accelerated methods based upon their estimated useful lives.

29

Interest Expense

Interest expense is reported when incurred and principally consists of interest and unused credit line fees on the credit facility.

Income Tax Expense

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rates were 26.4% and 26.3% for the three months ended June 30, 2025 and 2024, respectively. The effective income tax rates were 24.0% and 26.0% for the six months ended June 30, 2025 and 2024, respectively, compared to our federal statutory rate of 21%. The difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, excess tax expense or benefit and the use of federal employment tax credits.

Results of Operations — Consolidated

Three Months Ended June 30, 2025 Compared to Three Months Ended June 30, 2024

The following table sets forth our unaudited condensed consolidated results of operations.

	For the Three Months Ended June 30,
	2025						2024						Change
				% Of						% Of
				Net Service						Net Service
	Amount			Revenues			Amount			Revenues			Amount				%
	(Amounts in Thousands, Except Percentages)
Net service revenues	$	349,443			100.0	%	$	286,922			100.0	%	$	62,521		21.8	%
Cost of service revenues		235,566			67.4			193,764			67.5			41,802		21.6
Gross profit		113,877			32.6			93,158			32.5			20,719		22.2
General and administrative expenses		77,077			22.1			63,576			22.2			13,501		21.2
Depreciation and amortization		3,913			1.1			3,401			1.2			512		15.1
Total operating expenses		80,990			23.2			66,977			23.3			14,013		20.9
Operating income		32,887			9.4			26,181			9.1			6,706		25.6
Interest income		(583	)		(0.2	)		(474	)		(0.2	)		(109	)	23.0
Interest expense		3,525			1.0			2,114			0.7			1,411		66.7
Total interest expense, net		2,942			0.9			1,640			0.6			1,302		79.4
Income before income taxes		29,945			8.6			24,541			8.6			5,404		22.0
Income tax expense		7,893			2.3			6,462			2.3			1,431		22.1
Net income	$	22,052			6.3	%	$	18,079			6.3	%	$	3,973		22.0	%

Net service revenues increased by 21.8% to $349.4 million for the three months ended June 30, 2025 compared to $286.9 million for the three months ended June 30, 2024. Revenue increased by $56.4 million in our personal care segment, by $6.2 million in our hospice segment and remained constant at approximately $18.1 million in our home health segment during the three months ended June 30, 2025, compared to the same period in 2024. The increase in our personal care segment was primarily due to the completion of the Gentiva Acquisition on December 2, 2024. The increase in our hospice segment revenue was due to organic growth.

Gross profit, expressed as a percentage of net service revenues, increased to 32.6% for the three months ended June 30, 2025, compared to 32.5% for the same period in 2024 due to growth in our higher margin hospice segment and the New York Asset Sale.

General and administrative expenses increased to $77.1 million for the three months ended June 30, 2025, as compared to $63.6 million for the three months ended June 30, 2024. The increase in general and administrative expenses was primarily due to the Gentiva Acquisition that resulted in an increase in administrative employee wage, bonus, tax, and benefit costs of $9.0 million. General and administrative expenses, expressed as a percentage of net service revenues, decreased to 22.1% for the three months ended June 30, 2025, from 22.2% for the three months ended June 30, 2024.

30

Interest expense increased to $3.5 million for the three months ended June 30, 2025 from $2.1 million for the three months ended June 30, 2024. The increase in interest expense was primarily due to higher average outstanding borrowings held under our credit facility for the three months ended June 30, 2025,compared to the three months ended June 30, 2024.

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 26.4% and 26.3% for the three months ended June 30, 2025 and 2024, respectively. Our higher effective income tax rate for the three months ended June 30, 2025, was principally due to a higher excess tax expense with a higher benefit from the use of federal employment tax credits. For the three months ended June 30, 2025 and 2024, the excess tax expense and federal employment tax credits were 2.6% and 2.8%, respectively.

Six Months Ended June 30, 2025 Compared to Six Months Ended June 30, 2024

The following table sets forth our unaudited condensed consolidated results of operations.

	For the Six Months Ended June 30,
	2025						2024						Change
				% Of						% Of
				Net Service						Net Service
	Amount			Revenues			Amount			Revenues			Amount				%
	(Amounts in Thousands, Except Percentages)
Net service revenues	$	687,151			100.0	%	$	567,668			100.0	%	$	119,483		21.0	%
Cost of service revenues		465,597			67.8			386,333			68.1			79,264		20.5
Gross profit		221,554			32.2			181,335			31.9			40,219		22.2
General and administrative expenses		150,297			21.9			124,639			22.0			25,658		20.6
Depreciation and amortization		7,856			1.1			6,870			1.2			986		14.4
Total operating expenses		158,153			23.0			131,509			23.2			26,644		20.3
Operating income		63,401			9.2			49,826			8.8			13,575		27.2
Interest income		(1,085	)		(0.2	)		(897	)		(0.2	)		(188	)	21.0
Interest expense		7,543			1.1			4,872			0.9			2,671		54.8
Total interest expense, net		6,458			0.9			3,975			0.7			2,483		62.5
Income before income taxes		56,943			8.3			45,851			8.1			11,092		24.2
Income tax expense		13,663			2.0			11,942			2.1			1,721		14.4
Net income	$	43,280			6.3	%	$	33,909			6.0	%	$	9,371		27.6	%

Net service revenues increased by 21.0% to $687.2 million for the six months ended June 30, 2025 compared to $567.7 million for the six months ended June 30, 2024. Revenue increased by $106.6 million in our personal care segment, by $11.8 million in our hospice segment and by $1.1 million in our home health segment during the six months ended June 30, 2025, compared to the same period in 2024. The increase in our personal care and home health segments was primarily due to the completion of the Gentiva Acquisition on December 2, 2024. The increase in our hospice segment revenue was due to organic growth.

Gross profit, expressed as a percentage of net service revenues, increased to 32.2% for the six months ended June 30, 2025, compared to 31.9% for the same period in 2024 due to growth in hospice segment and the New York Asset Sale.

General and administrative expenses increased to $150.3 million for the six months ended June 30, 2025, as compared to $124.6 million for the six months ended June 30, 2024. The increase in general and administrative expenses was primarily due to the Gentiva Acquisition that resulted in an increase in administrative employee wage, bonus, tax, and benefit costs of $19.5 million. General and administrative expenses, expressed as a percentage of net service revenues, decreased to 21.9% for the six months ended June 30, 2025, from 22.0% for the six months ended June 30, 2024.

31

Interest expense increased to $7.5 million for the six months ended June 30, 2025 from $4.9 million for the six months ended June 30, 2024. The increase in interest expense was primarily due to higher average outstanding borrowings held under our credit facility for the six months ended June 30, 2025, compared to the six months ended June 30, 2024.

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 24.0% and 26.0% for the six months ended June 30, 2025 and 2024, respectively. Our lower effective income tax rate for the six months ended June 30, 2025, was principally due to a higher excess tax benefit with a higher benefit from the use of federal employment tax credits. For the six months ended June 30, 2025 and 2024, the excess tax benefit and federal employment tax credits were 4.8% and 3.1%, respectively.

Results of Operations – Segments

The following tables and related analysis summarize our operating results and business metrics by segment:

Personal Care Segment

	For the Three Months Ended June 30,																	For the Six Months Ended June 30,
	2025						2024						Change					2025						2024						Change
				% of						% of											% of						% of
				Segment						Segment											Segment						Segment
				Net Service						Net Service											Net Service						Net Service
	Amount			Revenues			Amount			Revenues			Amount				%	Amount			Revenues			Amount			Revenues			Amount				%
	(Amounts in Thousands, Except Percentages)																	(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$	269,183			100.0	%	$	212,817			100.0	%	$	56,366		26.5	%	$	527,469			100.0	%	$	420,820			100.0	%	$	106,649		25.3	%
Cost of services revenues		193,380			71.8			152,755			71.8			40,625		26.6			380,344			72.1			305,291			72.5			75,053		24.6
Gross profit		75,803			28.2			60,062			28.2			15,741		26.2			147,125			27.9			115,529			27.5			31,596		27.3
General and administrative expenses		24,163			9.0			16,973			8.0			7,190		42.4			47,894			9.1			32,418			7.7			15,476		47.7
Segment operating income	$	51,640			19.2	%	$	43,089			20.3	%	$	8,551		19.8	%	$	99,231			18.8	%	$	83,111			19.8	%	$	16,120		19.4	%
Business Metrics (Actual Numbers, Except Billable Hours in Thousands)
Locations at period end																			199						153
Average billable census * (1)		50,404						37,993						12,411		32.7	%		50,442						37,854						12,588		33.3	%
Billable hours * (2)		10,558						7,732						2,826		36.5			20,760						15,322						5,438		35.5
Average billable hours per census per month * (2)		69.8						67.7						2.1		3.1			68.6						67.4						1.2		1.8
Billable hours per business day * (2)		162,436						118,956						43,480		36.6			160,927						117,862						43,065		36.5
Revenues per billable hour * (2)	$	25.49					$	27.47					$	(1.98	)	(7.2	)%	$	25.41					$	27.41					$	(2.00	)	(7.3	)%
Same store growth revenue % * (3)		7.4	%					8.8	%					(1.4	)	(15.9	)		7.4	%					9.3	%					(1.9	)	(20.4	)

(1) Average billable census is the number of unique clients receiving a billable service during the year and is the total census divided by months in operation during the period.

(2) Billable hours is the total number of hours served to clients during the period. Average billable hours per census per month is billable hours divided by average billable census. Billable hours per day is total billable hours divided by the number of business days in the period. Revenues per billable hour is revenue, attributed to billable bonus hours, divided by billable hours.

32

(3) Same store growth reflects the change in year-over-year revenue for the same store base. We define the same store base to include those stores open for at least 52 full weeks. This measure highlights the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures and ARPA associated revenue from this calculation.

* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.

The personal care segment derives a significant amount of its net service revenues from operations in Illinois, which represented 33.0% and 38.6% of our net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 33.0% and 38.5% of our net service revenues for the six months ended June 30, 2025 and 2024, respectively. One payor, the Illinois Department on Aging, accounted for 18.6% and 21.1% of net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 18.6% and 20.9% of net service revenues for the six months ended June 30, 2025 and 2024, respectively.

Net service revenues from state, local, and other governmental programs accounted for 51.4% and 53.1% of net service revenues for the three months ended June 30, 2025 and 2024, respectively. Managed care organizations accounted for 45.3% and 44.2% of net service revenues for the three months ended June 30, 2025 and 2024, respectively, with commercial insurance, private pay, and other payors accounting for the remainder of net service revenues. Net service revenues from state, local, and other governmental programs accounted for 51.4% and 52.5% of net service revenues for the six months ended June 30, 2025 and 2024, respectively. Managed care organizations accounted for 45.3% and 44.8% of net service revenues for the six months ended June 30, 2025 and 2024, respectively, with commercial insurance, private pay, and other payors accounting for the remainder of net service revenues.

Net service revenues increased by 26.5% for the three months ended June 30, 2025 compared to the three months ended June 30, 2024. Net service revenues included a 7.2% decrease in revenues per billable hour for the three months ended June 30, 2025, due to lower reimbursement rates attributable to the Gentiva Acquisition, as well as the New York Asset Sale, compared to the three months ended June 30, 2024.

Gross profit, expressed as a percentage of net service revenues, increased to 27.9% for the six months ended June 30, 2025 from 27.5% for the six months ended June 30, 2024. This increase was due to decreases in direct payroll and benefits expenses as a percentage of revenue for the six months ended June 30, 2025 primarily related to the New York Asset Sale.

The personal care segment’s general and administrative expenses primarily consist of administrative employee wages, taxes, and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 9.1% and 7.7% for the six months ended June 30, 2025 and 2024, respectively.

33

Hospice Segment

	For the Three Months Ended June 30,																	For the Six Months Ended June 30,
	2025						2024						Change					2025						2024						Change
				% of						% of											% of						% of
				Segment						Segment											Segment						Segment
				Net Service						Net Service											Net Service						Net Service
	Amount			Revenues			Amount			Revenues			Amount				%	Amount			Revenues			Amount			Revenues			Amount			%
	(Amounts in Thousands, Except Percentages)																	(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$	62,212			100.0	%	$	56,030			100.0	%	$	6,182		11.0	%	$	123,649			100.0	%	$	111,893			100.0	%	$	11,756	10.5	%
Cost of services revenues		32,414			52.1			29,730			53.1			2,684		9.0			64,684			52.3			58,697			52.5			5,987	10.2
Gross profit		29,798			47.9			26,300			46.9			3,498		13.3			58,965			47.7			53,196			47.5			5,769	10.8
General and administrative expenses		14,975			24.1			13,466			24.0			1,509		11.2			29,526			23.9			26,905			24.0			2,621	9.7
Segment operating income	$	14,823			23.8	%	$	12,834			22.9	%	$	1,989		15.5	%	$	29,439			23.8	%	$	26,291			23.5	%	$	3,148	12.0	%
Business Metrics (Actual Numbers)
Locations at period end																			38						38
Admissions * (1)		3,260						3,194						66		2.1	%		6,734						6,666						68	1.0	%
Average daily census * (2)		3,720						3,477						243		7.0			3,618						3,418						200	5.9
Average discharge length of stay * (3)		90.6						92.6						(2.0	)	(2.2	)		94.1						91.1						3.0	3.3
Patient days * (4)		338,505						316,451						22,054		7.0			654,824						622,081						32,743	5.3
Revenue per patient day * (5)	$	184.92					$	179.47					$	5.45		3.0		$	189.42					$	181.10					$	8.32	4.6
Organic growth
- Revenue * (6)		10.0	%					6.3	%					3.7		58.7			9.9	%					6.1	%					3.8	62.3
- Average daily census * (6)		7.0	%					1.7	%					5.3		311.8	%		5.8	%					0.4	%					5.4	1350.0	%

(1) Represents referral process and new patients on service during the period.

(2) Average daily census is total patient days divided by the number of days in the period.

(3) Average length of stay is the average number of days a patient is on service, calculated upon discharge, and is total patient days divided by total discharges in the period.

(4) Patient days is days of service for all patients in the period.

(5) Revenue per patient day is hospice revenue divided by the number of patient days in the period.

(6) Revenue organic growth and average daily census organic growth reflect the change in year-over-year revenue and average daily census for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures.

* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.

34

The hospice segment generates revenue by providing care to patients with a life expectancy of six months or less, as well as related services for their families. Hospice offers four levels of care, as defined by Medicare, to meet the varying needs of patients and their families. The four levels of hospice include routine home care, continuous home care, general inpatient care and respite care. Our hospice segment principally provides routine home care.

Net service revenues from Medicare accounted for 93.0% and 91.2% for the three months ended June 30, 2025 and 2024, respectively, and 92.7% and 91.0% for the six months ended June 30, 2025 and 2024, respectively. Net service revenues from managed care organizations accounted for 3.2% and 3.4% for the three months ended June 30, 2025 and 2024, respectively, and for 3.3% for both the six months ended June 30, 2025 and 2024.

Net service revenues increased by $6.2 million and $11.8 million for the three and six months ended June 30, 2025 compared to the three and six months ended June 30, 2024, primarily attributed to organic growth in average daily census.

Gross profit, expressed as a percentage of net service revenues, was 47.9% and 46.9% for the three months ended June 30, 2025 and 2024, respectively, and 47.7% and 47.5% for the six months ended June 30, 2025 and 2024, respectively. For the three and six months ended June 30, 2025, the increase was mainly attributed to organic growth.

The hospice segment’s general and administrative expenses primarily consist of administrative employee wage, tax, and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 24.1% and 24.0% for the three months ended June 30, 2025 and 2024, respectively, and 23.9% and 24.0% for the six months ended June 30, 2025 and 2024, respectively. 

Home Health Segment

	For the Three Months Ended June 30,																	For the Six Months Ended June 30,
	2025						2024						Change					2025						2024						Change
				% of						% of											% of						% of
				Segment						Segment											Segment						Segment
				Net Service						Net Service											Net Service						Net Service
	Amount			Revenues			Amount			Revenues			Amount				%	Amount			Revenues			Amount			Revenues			Amount				%
	(Amounts in Thousands, Except Percentages)																	(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$	18,048			100.0	%	$	18,075			100.0	%	$	(27	)	(0.1	)%	$	36,033			100.0	%	$	34,955			100.0	%	$	1,078		3.1	%
Cost of services revenues		9,771			54.1			11,279			62.4			(1,508	)	(13.4	)		20,569			57.1			22,345			63.9			(1,776	)	(7.9	)
Gross profit		8,277			45.9			6,796			37.6			1,481		21.8			15,464			42.9			12,610			36.1			2,854		22.6
General and administrative expenses		3,895			21.6			4,572			25.3			(677	)	(14.8	)		8,068			22.4			9,109			26.1			(1,041	)	(11.4	)
Segment operating income	$	4,382			24.3	%	$	2,224			12.3	%	$	2,158		97.0	%	$	7,396			20.5	%	$	3,501			10.0	%	$	3,895		111.3	%
Business Metrics (Actual Numbers)
Locations at period end																			23						23
New admissions * (1)		4,568						4,993						(425	)	(8.5	)%		9,276						9,820						(544	)	(5.5	)%
Recertifications * (2)		2,833						3,277						(444	)	(13.5	)		5,815						6,445						(630	)	(9.8	)
Total volume * (3)		7,401						8,210						(809.0	)	(9.9	)		15,091						16,265						(1,174.0	)	(7.2	)
Visits * (4)		94,692						111,053						(16,361	)	(14.7	)		189,285						217,984						(28,699	)	(13.2	)
Organic growth
- Revenue * (5)		(6.0	)%					1.6	%					(7.6	)	(475.0	)		(2.5	)%					(7.1	)%					4.6		(64.8	)
- Admissions * (5)		(7.6	)%					9.4	%					(17.0	)	(180.9	)%		(5.6	)%					2.3	%					(7.9	)	(343.5	)%

(1) Represents new patients during the period.

35

(2) A home health certification period is an episode of care that begins with a start of care visit and continues for 60 days. If at the end of the initial episode of care, the patient continues to require home health services, a recertification is required. This represents the number of recertifications during the period.

(3) Total volume is total admissions and total recertifications in the period.

(4) Represents number of services to patients in the period.

(5) Revenue organic growth and admissions organic growth reflect the change in year-over-year revenue and admissions for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the performance of existing stores, while excluding the impact of acquisitions, new store openings, and closures.

* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.

The home health segment generates net service revenues by providing home health services on a short-term, intermittent or episodic basis to individuals, generally to treat an illness or injury. Net service revenues from Medicare accounted for 69.4% and 69.3%, managed care organizations accounted for 23.6% and 25.9%, and state, local, and other governmental programs accounted for 4.4% and 0.2% for the three months ended June 30, 2025 and 2024, respectively. Net service revenues from Medicare accounted for 69.7% and 69.2%, managed care organizations accounted for 22.4% and 26.0%, and state, local, and other governmental programs accounted for 5.2% and 0.2% for the six months ended June 30, 2025 and 2024, respectively. Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System, which uses national, standardized 30-day period payment rates for periods of care. CMS uses the PDGM as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics. An outlier adjustment may be paid for periods of care in which costs exceed a specific threshold amount.

Net service revenues remained constant for the three months ended June 30, 2025, compared to the three months ended June 30, 2024, and increased by $1.1 million for the six months ended June 30, 2025, compared to the six months ended June 30, 2024, primarily due to the Gentiva Acquisition.

Gross profit, expressed as a percentage of net service revenues, was 45.9% and 37.6% for the three months ended June 30, 2025 and 2024, respectively, and 42.9% and 36.1% for the six months ended June 30, 2025 and 2024, respectively. For the three and six months ended June 30, 2025, the increase was mainly attributed to a decrease in direct care wages, taxes and benefit costs as a percentage of net service revenues, compared to the three and six months ended June 30, 2024.

The home health segment’s general and administrative expenses primarily consist of administrative employee wage, tax and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 21.6% and 25.3% for the three months ended June 30, 2025 and 2024, respectively, and 22.4% and 26.1% for the six months ended June 30, 2025 and 2024, respectively. General and administrative expenses for the three and six months ended June 30, 2025 decreased compared to the corresponding period in 2024, primarily due to more efficient operations for administrative employees for the three and six months ended June 30, 2025.

36

Liquidity and Capital Resources

Overview

Our primary sources of liquidity are cash on hand and cash from operations and borrowings under our credit facility. At June 30, 2025 and December 31, 2024, we had cash balances of $91.2 million and $98.9 million, respectively. At June 30, 2025, we had a $650.0 million revolving credit facility and a $150.0 million incremental loan facility, which may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility was extended to July 30, 2028.

During the six months ended June 30, 2025, we used $3.4 million in cash to fund the Jacksonville Acquisition and the Great Lakes Acquisition and repaid $50.0 million under our revolving credit facility. As of June 30, 2025, we had a total of $173.0 million in revolving loans, with an interest rate of 6.07% outstanding on our credit facility and after giving effect to the amount drawn on our credit facility, approximately $8.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), we had $635.6 million of capacity and $454.6 million available for borrowing under our credit facility. At December 31, 2024, we had a total of $223.0 million revolving credit loans, with an interest rate of 6.34%, outstanding on our credit facility.

Our credit facility requires us to maintain a total net leverage ratio not exceeding 3.75:1.00. At June 30, 2025, we were in compliance with our financial covenants under the Credit Agreement. Although we believe our liquidity position remains strong, we can provide no assurance that we will remain in compliance with the covenants in our Credit Agreement, and in the future, it may prove necessary to seek an amendment with the bank lending group under our credit facility. Additionally, there can be no assurance that we will be able to raise additional funds on terms acceptable to us, if at all.

See Note 8 to the Notes to Unaudited Condensed Consolidated Financial Statements, Long-Term Debt, for additional details of our long-term debt.

Current Macroeconomic Conditions and American Rescue Plan Act of 2021 Relief Funding

Economic conditions in the United States continue to be challenging in various respects. For example, the United States economy continues to experience inflationary pressures, elevated interest rates, challenging labor market conditions and uncertainty regarding the impact of increased tariffs and trade disruptions. Any economic downturn would pose a risk to states’ revenues, which in turn could affect our reimbursements and collections received for services rendered. Depending on the severity and length of any potential economic downturn as well as the extent of any federal support, states could face significant fiscal challenges and revise their revenue forecasts and adjust their budgets, and sales tax collections and income tax withholdings could be depressed.

ARPA Spending Plans

To mitigate the fiscal effects of the COVID-19 public health emergency, the ARPA provided for a 10 percentage point increase in federal matching funds for Medicaid HCBS from April 1, 2021, through March 31, 2022, provided the state satisfied certain conditions. States were generally permitted to use the state funds equivalent to the additional federal funds through March 31, 2025, but CMS granted extensions to several states, permitting some state spending plans to continue until as late as mid-2026. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021.

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses.

During the three and six months ended June 30, 2025, the Company did not receive additional state funding provided by the ARPA. Of the total state funding received by the Company pursuant to the ARPA through June 30, 2025, the Company utilized $0.8 million and $3.3 million during the three and six months ended June 30, 2025, respectively, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of June 30, 2025, the deferred portion of ARPA funding of $7.9 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

37

The following table summarizes changes in our cash flows:

	For the Six Months Ended June 30,
	2025			2024
	(Amounts in Thousands)
Net cash provided by operating activities	$	41,478		$	57,491
Net cash used in investing activities		317			1,798
Net cash (used in) provided by financing activities		(49,530	)		49,225

Six Months Ended June 30, 2025 Compared to Six Months Ended June 30, 2024

Cash flows from operating activities represent the inflow of cash from our payors and the outflow of cash for payroll and payroll taxes, operating expenses, interest, and taxes. Net cash provided by operating activities was $41.5 million for the six months ended June 30, 2025, compared to net cash provided by operating activities of $57.5 million for the same period in 2024. The decrease in cash provided by operations was primarily due to the timing of receipts on accounts receivable and the timing of government stimulus funds. The changes in accounts receivable were primarily related to the growth in revenue and a decrease in days sales outstanding (“DSO”) during the six months ended June 30, 2025 as compared to the six months ended June 30, 2024. The related receivables due from the Illinois Department on Aging represented 18.6% and 21.7% of the Company’s net accounts receivable at June 30, 2025 and June 30, 2024, respectively.

Net cash used in investing activities for the six months ended June 30, 2025, primarily consisted of $3.4 million of net cash used for the Jacksonville Acquisition and the Great Lakes Acquisition, $3.1 million of cash used for property and equipment purchases, primarily related to our ongoing investments in technology infrastructure fixed assets, offset by $3.8 million in proceeds received relating to the New York Asset Sale and $2.9 million in proceeds received relating to the Gentiva Acquisition. Net cash used in investing activities for the six months ended June 30, 2024 primarily consisted of $0.4 million of net cash used for the Upstate acquisition and $2.4 million of cash used for property and equipment purchases, offset by $4.6 million in proceeds received relating to the New York Asset Sale.

Net cash used in financing activities for the six months ended June 30, 2025, primarily consisted of a $50.0 million payment on our revolving credit facility, offset by cash received from the exercise of stock options of $0.5 million. Net cash used in financing activities for the six months ended June 30, 2024 primarily consisted of $126.4 million payment on our revolving credit facility, offset by $175.6 million in net proceeds received from the Public Offering.

Outstanding Accounts Receivable

Gross accounts receivable as of June 30, 2025 and December 31, 2024 were approximately $143.1 million and $126.4 million, respectively. Outstanding accounts receivable, net of allowance for credit losses, increased by $17.2 million as of June 30, 2025 as compared to December 31, 2024. Accounts receivable for the Illinois Department on Aging increased approximately $6.3 million during the six months ended June 30, 2025. Our collection procedures include review of account aging and direct contact with our payors. We have historically not used collection agencies. An uncollectible amount is written off to the allowance account after reasonable collection efforts have been exhausted.

We calculate our DSO by taking the trade accounts receivable outstanding, net of allowance for credit losses for doubtful accounts, divided by the net service revenues for the last quarter, multiplied by the number of days in that quarter. Our DSOs were 38 days and 39 days at June 30, 2025 and December 31, 2024, respectively. The DSOs for our largest payor, the Illinois Department on Aging, were 39 days and 40 days at June 30, 2025 and December 31, 2024, respectively.

38

Off-Balance Sheet Arrangements

As of June 30, 2025, we did not have any off-balance sheet guarantees or arrangements with unconsolidated entities.

Critical Accounting Policies and Estimates

There have been no material changes to our critical accounting policies and estimates previously disclosed under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates” set forth in Part II, Item 7 of our Annual Report on Form 10-K for the period ended December 31, 2024, filed on February 25, 2025.

Recently Issued Accounting Pronouncements

Refer to Note 2 to the Notes to Unaudited Condensed Consolidated Financial Statements for further discussion.

39

ITEM 3.       QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk associated with changes in interest rates on our variable rate long-term debt. As of June 30, 2025, we had outstanding borrowings of approximately $173.0 million on our credit facility, all of such borrowings were subject to variable interest rates. If the variable rates on this debt were 100 basis points higher than the rate applicable to the borrowing during the six month period ended June 30, 2025, our net income would have decreased by $0.8 million, or $0.04 per diluted share. We do not currently have any derivative or hedging arrangements, or other known exposures, to changes in interest rates.

ITEM 4.       CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2025. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2025.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the fiscal quarter ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

40

PART II – OTHER INFORMATION

Item 1.         Legal Proceedings

Legal Proceedings

From time to time, we are subject to legal and/or administrative proceedings incidental to our business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on our financial position and results of operations.

Item 1A.      Risk Factors

Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors discussed under the caption “Risk Factors” set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2024, filed on February 25, 2025. There have been no material changes to the risk factors previously disclosed under the caption “Risk Factors” in our Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, or operating results.

Item 2.         Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.         Defaults Upon Senior Securities

None.

Item 4.         Mine Safety Disclosures

None.

Item 5.         Other Information

Not applicable. Without limiting the generality of the foregoing, during the quarter ended June 30, 2025, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements, as such terms are defined in Item 408(a) of Regulation S-K.

41

Item 6.         Exhibits

EXHIBIT INDEX

		Incorporated by Reference
Exhibit Number	Description of Document	Form	File No.	Date Filing	Exhibit Number
3.1	Amended and Restated Certificate of Incorporation of the Company dated as of October 27, 2009.	10-Q	001-34504	11/20/2009	3.1
3.2	Amended and Restated Bylaws of the Company, as amended by the First Amendment to the Amended and Restated Bylaws.	10-Q	001-34504	05/09/2013	3.2
4.1	Form of Common Stock Certificate.	S-1	333-160634	10/02/2009	4.1
31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Calculation Linkbase Document.
101.LAB	Inline XBRL Taxonomy Label Linkbase Document.
101.PRE	Inline XBRL Presentation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

42

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ADDUS HOMECARE CORPORATION
Date: August 5, 2025	By:	/s/ R. DIRK ALLISON
		R. Dirk Allison Chairman and Chief Executive Officer (As Principal Executive Officer)
Date: August 5, 2025	By:	/s/ BRIAN POFF
		Brian Poff Chief Financial Officer (As Principal Financial Officer)

43

EX-31.1

Exhibit 31.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, R. Dirk Allison, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Addus HomeCare Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 5, 2025	By:	/s/ R. Dirk Allison
		R. Dirk Allison
		Chairman and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Brian Poff, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Addus HomeCare Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 5, 2025	By:	/s/ Brian Poff
		Brian Poff
		Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

(AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025 of Addus HomeCare Corporation (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, R. Dirk Allison, Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 5, 2025	By:	/s/ R. Dirk Allison
		R. Dirk Allison
		Chairman and Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

(AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025 of Addus HomeCare Corporation (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian Poff, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 5, 2025	By:	/s/ Brian Poff
		Brian Poff
		Chief Financial Officer

XML

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2025	Jul. 29, 2025
Document Information [Line Items]
Entity Central Index Key	0001468328
Entity Registrant Name	Addus HomeCare Corp
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2025
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2025
Document Transition Report	false
Entity File Number	001-34504
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-5340172
Entity Address, Address Line One	6303 Cowboys Way, Suite 600
Entity Address, City or Town	Frisco
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75034
City Area Code	469
Local Phone Number	535-8200
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	ADUS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		18,407,239

XML

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current assets
Cash	$ 91,176	$ 98,911
Accounts receivable, net of allowances	140,098	122,880
Prepaid expenses and other current assets	31,771	38,591
Total current assets	263,045	260,382
Property and equipment, net of accumulated depreciation and amortization	24,441	24,703
Other assets
Goodwill	969,824	970,558
Intangibles, net of accumulated amortization	105,656	109,643
Operating lease assets, net	45,965	47,348
Total other assets	1,121,445	1,127,549
Total assets	1,408,931	1,412,634
Current liabilities
Accounts payable	15,687	27,176
Accrued payroll	68,441	62,053
Accrued expenses	33,054	28,959
Operating lease liabilities, current portion	12,969	12,800
Government stimulus advances	7,927	11,239
Accrued workers' compensation insurance	13,305	13,644
Total current liabilities	151,383	155,871
Long-term liabilities
Long-term debt, less current portion, net of debt issuance costs	169,059	218,443
Long-term operating lease liabilities	40,223	41,883
Deferred income tax	26,287	25,820
Other long-term liabilities	125	125
Total long-term liabilities	235,694	286,271
Total liabilities	387,077	442,142
Stockholders' equity
Common stock—$.001 par value; 40,000 authorized and 18,407 and 18,148 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	18	18
Additional paid-in capital	602,126	594,044
Retained earnings	419,710	376,430
Total stockholders' equity	1,021,854	970,492
Total liabilities and stockholders' equity	$ 1,408,931	$ 1,412,634

XML

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares shares in Thousands	Jun. 30, 2025	Dec. 31, 2024
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	40,000	40,000
Common stock, shares issued (in shares)	18,407	18,148
Common stock, shares outstanding (in shares)	18,407	18,148

XML

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Net service revenues	$ 349,443	$ 286,922	$ 687,151	$ 567,668
Cost of service revenues	235,566	193,764	465,597	386,333
Gross profit	113,877	93,158	221,554	181,335
General and administrative expenses	77,077	63,576	150,297	124,639
Depreciation and amortization	3,913	3,401	7,856	6,870
Total operating expenses	80,990	66,977	158,153	131,509
Operating income	32,887	26,181	63,401	49,826
Interest income	(583)	(474)	(1,085)	(897)
Interest expense	3,525	2,114	7,543	4,872
Total interest expense, net	2,942	1,640	6,458	3,975
Income before income taxes	29,945	24,541	56,943	45,851
Income tax expense	7,893	6,462	13,663	11,942
Net income	$ 22,052	$ 18,079	$ 43,280	$ 33,909
Net income per common share
Basic income per share (in dollars per share)	$ 1.22	$ 1.12	$ 2.4	$ 2.1
Diluted income per share (in dollars per share)	$ 1.2	$ 1.1	$ 2.36	$ 2.06
Weighted average number of common shares and potential common shares outstanding:
Basic (in shares)	18,045	16,177	18,011	16,120
Diluted (in shares)	18,332	16,498	18,340	16,449

XML

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2023	16,227
Balance at Dec. 31, 2023	$ 16	$ 403,846	$ 302,832	$ 706,694
Issuance of shares of common stock under restricted stock award agreements (in shares)	151
Issuance of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Forfeiture of shares of common stock under restricted stock award agreements (in shares)	(3)
Forfeiture of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Stock-based compensation	$ 0	5,474	0	5,474
Shares issued for exercise of stock options (in shares)	0
Shares issued for exercise of stock options	$ 0	0	0	0
Net income	$ 0	0	33,909	33,909
Shares issued in Public offering, net of offering costs (in shares)	1,725
Shares issued in Public offering, net of offering costs	$ 2	175,576	0	175,578
Balance (in shares) at Jun. 30, 2024	18,100
Balance at Jun. 30, 2024	$ 18	584,896	336,741	921,655
Balance (in shares) at Mar. 31, 2024	16,370
Balance at Mar. 31, 2024	$ 16	406,465	318,662	725,143
Issuance of shares of common stock under restricted stock award agreements (in shares)	8
Issuance of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Forfeiture of shares of common stock under restricted stock award agreements (in shares)	(3)
Forfeiture of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Stock-based compensation	$ 0	2,855	0	2,855
Shares issued for exercise of stock options (in shares)	0
Shares issued for exercise of stock options	$ 0	0	0	0
Net income	$ 0	0	18,079	18,079
Shares issued in Public offering, net of offering costs (in shares)	1,725
Shares issued in Public offering, net of offering costs	$ 2	175,576	0	175,578
Balance (in shares) at Jun. 30, 2024	18,100
Balance at Jun. 30, 2024	$ 18	584,896	336,741	921,655
Balance (in shares) at Dec. 31, 2024	18,148
Balance at Dec. 31, 2024	$ 18	594,044	376,430	970,492
Issuance of shares of common stock under restricted stock award agreements (in shares)	237
Issuance of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Forfeiture of shares of common stock under restricted stock award agreements (in shares)	(3)
Forfeiture of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Stock-based compensation	$ 0	7,590	0	7,590
Shares issued for exercise of stock options (in shares)	25
Shares issued for exercise of stock options	$ 0	492	0	492
Net income	$ 0	0	43,280	43,280
Balance (in shares) at Jun. 30, 2025	18,407
Balance at Jun. 30, 2025	$ 18	602,126	419,710	1,021,854
Balance (in shares) at Mar. 31, 2025	18,399
Balance at Mar. 31, 2025	$ 18	597,706	397,658	995,382
Issuance of shares of common stock under restricted stock award agreements (in shares)	10
Issuance of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Forfeiture of shares of common stock under restricted stock award agreements (in shares)	(2)
Forfeiture of shares of common stock under restricted stock award agreements	$ 0	0	0	0
Stock-based compensation	$ 0	4,420	0	4,420
Shares issued for exercise of stock options (in shares)	0
Shares issued for exercise of stock options	$ 0	0	0	0
Net income	$ 0	0	22,052	22,052
Balance (in shares) at Jun. 30, 2025	18,407
Balance at Jun. 30, 2025	$ 18	$ 602,126	$ 419,710	$ 1,021,854

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income	$ 43,280	$ 33,909
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions:
Depreciation and amortization	7,856	6,870
Deferred income taxes	467	264
Stock-based compensation	7,590	5,474
Amortization of debt issuance costs under the credit facility	638	430
Provision for credit losses	681	486
Gain on disposal of assets	(8)	(5)
Loss on termination of operating leases	19	10
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(15,936)	5,362
Prepaid expenses and other current assets	2,856	7,127
Government stimulus advances	(3,312)	7,235
Accounts payable	(12,844)	(6,333)
Accrued payroll	6,446	(1,449)
Accrued expenses and other long-term liabilities	3,745	(1,889)
Net cash provided by operating activities	41,478	57,491
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	(3,350)	(400)
Purchases of property and equipment	(3,136)	(2,421)
Proceeds received from disposal of assets	18	19
Proceeds received from previous acquisition	2,937	0
Proceeds received from divestiture of business	3,848	4,600
Net cash used in investing activities	317	1,798
Cash flows from financing activities:
Payments on revolver — credit facility	(50,000)	(126,353)
Payments for debt issuance costs under the credit facility	(22)	0
Proceeds from Public offering	0	175,578
Cash received from exercise of stock options	492	0
Net cash (used in) provided by financing activities	(49,530)	49,225
Net change in cash	(7,735)	108,514
Cash, at beginning of period	98,911	64,791
Cash, at end of period	91,176	173,305
Supplemental disclosures of cash flow information:
Cash paid for interest	7,019	4,491
Cash paid for income taxes	$ 4,861	$ 13,986

XML

Note 1 - Nature of Operations, Consolidation, and Presentation of Financial Statements

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us”, or “our”) operate as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill, or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The Company’s payors include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals.

Basis of Presentation

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of  December 31, 2024 has been derived from the Company’s audited financial statements for the year ended  December 31, 2024 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended  December 31, 2024 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein.

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

Principles of Consolidation

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

XML

Note 2 - Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Significant Accounting Policies [Text Block]

2. Summary of Significant Accounting Policies

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles and business combinations, and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.

Computation of Weighted Average Shares

The following table sets forth the computation of basic and diluted common shares:

	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	(Amounts in thousands)				(Amounts in thousands)
	2025		2024		2025		2024
Weighted average number of shares outstanding for basic per share calculation		18,045		16,177		18,011		16,120
Effect of dilutive potential shares:
Stock options		219		251		221		239
Restricted stock awards		68		70		108		90
Adjusted weighted average shares for diluted per share calculation		18,332		16,498		18,340		16,449
Anti-dilutive shares:
Stock options		—		19		—		42
Restricted stock awards		9		8		9		8

Recently Adopted Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Improvements to Reportable Segment Disclosures, which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require, among other things, disclosure of significant segment expenses that are regularly provided to an entity’s chief operating decision maker (“CODM”) and a description of other segment items (the difference between segment revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss) by reportable segment, as well as disclosure of the title and position of the CODM, and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The ASU was adopted in connection with the Company's most recent Annual Report on Form 10-K, which included significant segment expenses reviewed by the Company’s CODM, but did not have a material impact on the Company’s results of operations, financial position, or cash flows.

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, may be applied on a prospective basis with the option to apply the standard retrospectively, and allows for early adoption. These requirements are not expected to have a material impact on the Company’s financial statements and will expand income tax disclosures.

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which intends to provide investors more detailed disclosures around specific types of expenses. The new disclosures require certain details for expenses presented on the face of the Consolidated Statements of Operations as well as selling expenses to be presented in the notes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. The Company is currently assessing the impact and timing of adopting the updated provisions.

XML

Note 3 - Divesture

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

3. Divestiture

Effective May 20, 2024, the Company entered into a definitive asset purchase agreement to sell all of the Company’s New York operations for a purchase price of up to $23.0 million in cash, subject to certain adjustments, including adjustments for future operating requirements (the “New York Asset Sale”). The purchase price included 50% cash consideration, paid out as an initial payment of $4.6 million and $6.9 million paid pro rata as a deferred payment as caregivers are transferred, and 50% in the form of contingent consideration for the Company’s New York Consumer Directed Personal Assistance Program (“CDPAP”) business. The Company entered into a consulting agreement with the purchaser effective May 20, 2024, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coordination of the transfer of clients and caregivers occurs, and the change of control takes place. The Company determined that the consulting agreement gave it the ability to control the business until October 2024, when the Company determined that it no longer controlled the business as it transferred more than 50% of the clients and caregivers and therefore qualified for sale consideration of the New York Asset Sale. As a result, the Company deconsolidated the results of its New York operations and recorded a gain on divestiture of $3.7 million during the year ended December 31, 2024. The gain was reflected within general and administrative expenses on the consolidated statement of operations.

In connection with this transaction, the Company ceased operations in New York. During the six months ended June 30, 2025, the Company recorded deferred payments of $3.8 million with the remaining $2.3 million due from the purchaser reflected within prepaid expenses and other current assets on the condensed consolidated balance sheets as of June 30, 2025. No amount was recorded related to the CDPAP business contingent consideration.

The New York Asset Sale did not qualify as a discontinued operation because it did not represent a strategic shift that has or will have a major effect on the Company’s operation or financial results.

Goodwill and intangible assets of $2.9 million and $4.2 million, respectively, were derecognized in connection with the divestiture. The carrying amounts of the assets and liabilities associated with the New York personal care operations included in our Consolidated Balance Sheets as of June 30, 2025 were as follows (amounts in thousands):

	June 30, 2025
Assets
Current assets
Accounts receivable, net of allowances	$	—
Prepaid expenses and other current assets		11
Total current assets		11
Property and equipment, net of accumulated depreciation and amortization		—
Other assets
Goodwill		—
Intangibles, net of accumulated amortization		—
Operating lease assets, net		2,910
Total other assets		2,910
Total assets	$	2,921
Liabilities
Current liabilities
Accounts payable	$	1,064
Accrued payroll		8
Accrued expenses		599
Operating lease liabilities, current portion		642
Total current liabilities		2,313
Long-term liabilities
Operating lease liabilities, long-term portion		2,187
Total liabilities	$	4,500

XML

Note 4 - Leases

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Lessee, Operating Leases [Text Block]

4. Leases

Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:

	June 30, 2025		December 31, 2024
	(Amounts in Thousands)
Operating lease assets, net	$	45,965	$	47,348
Short-term operating lease liabilities		12,969		12,800
Long-term operating lease liabilities		40,223		41,883
Total operating lease liabilities	$	53,192	$	54,683

Lease Costs

Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

	For the Three Months Ended June 30,					For the Six Months Ended June 30,
	(Amounts in Thousands)					(Amounts in Thousands)
	2025		2024			2025			2024
Operating lease costs	$	3,651	$	3,373		$	7,308		$	6,669
Short-term lease costs		271		179			555			380
Total lease costs		3,922		3,552			7,863			7,049
Less: sublease income		—		(491	)		(226	)		(1,089	)
Total lease costs, net	$	3,922	$	3,061		$	7,637		$	5,960

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates were as follows:

	June 30, 2025			December 31, 2024
Operating leases:
Weighted average remaining lease term		5.37			5.48
Weighted average discount rate		6.32	%		6.20	%

Maturity of Lease Liabilities

Remaining operating lease payments as of  June 30, 2025 were as follows:

	Operating Leases
	(Amounts in Thousands)
Due in the 12-month period ended June 30,
2026	$	15,739
2027		12,746
2028		9,459
2029		6,946
2030		6,200
Thereafter		12,311
Total future minimum rental commitments		63,401
Less: Imputed interest		(10,209	)
Total lease liabilities	$	53,192

Supplemental Cash Flows Information

	For the Six Months Ended June 30,
	(Amounts in Thousands)
	2025		2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	8,368	$	7,224
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	5,158	$	4,509

XML

Note 5 - Goodwill and Intangible Assets

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Goodwill and Intangible Assets Disclosure [Text Block]

5. Goodwill and Intangible Assets

A summary of the goodwill by segment and related adjustments is provided below:

						Home
	Hospice		Personal Care			Health			Total
	(Amounts in Thousands)
Goodwill as of December 31, 2024	$	432,840	$	442,526		$	95,192		$	970,558
Additions for acquisitions		—		3,350			—			3,350
Adjustments to previously recorded goodwill		26		(3,768	)		(342	)		(4,084	)
Goodwill as of June 30, 2025	$	432,866	$	442,108		$	94,850		$	969,824

On January 1, 2025, the Company completed its acquisition of its Jacksonville affiliate for approximately $0.8 million (the “Jacksonville Acquisition”), with funding provided by available cash. With the Jacksonville Acquisition, the Company expanded its personal care segment in Florida and recorded goodwill of $0.8 million.

On March 1, 2025, the Company completed its acquisition of the assets of Great Lakes Home Care Unlimited, LLC for $2.6 million (the “Great Lakes Acquisition”), with funding provided by available cash. With the Great Lakes Acquisition, the Company expanded its personal care segment in Michigan and recognized goodwill in its personal care segment of $2.6 million.

During the three and six months ended June 30, 2025, the Company recorded $2.5 million and $4.1 million, respectively, related to measurement period adjustments to previously recorded goodwill including $2.9 million of proceeds received in connection with the Gentiva Acquisition. 

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements, and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from one to twenty years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from three to fifteen years.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following:

		June 30, 2025							December 31, 2024
		(Amounts in Thousands)							(Amounts in Thousands)
	Estimated Useful	Gross		Accumulated			Net		Gross		Accumulated			Net
	Life (years)	carrying value		amortization			carrying value		carrying value		amortization			carrying value
Customer and referral relationships	3 - 15	$	34,201	$	(33,461	)	$	740	$	34,201	$	(33,255	)	$	946
Trade names and trademarks	1 - 20		59,366		(24,217	)		35,149		59,366		(21,900	)		37,466
Non-competition agreement	3 - 5		6,728		(6,476	)		252		6,728		(6,263	)		465
State Licenses	6 - 10		24,981		(2,494	)		22,487		24,981		(1,243	)		23,738
State Licenses	Indefinite		47,028		—			47,028		47,028		—			47,028
Total intangible assets		$	172,304	$	(66,648	)	$	105,656	$	172,304	$	(62,661	)	$	109,643

Amortization expense related to the intangible assets was $2.0 million and $4.0 million for the three and six months ended June 30, 2025, respectively, and $1.8 million and $3.6 million for the three and six months ended June 30, 2024, respectively. The weighted average remaining useful lives of identifiable intangible assets as of  June 30, 2025 was 9.45 years.

XML

Note 6 - Details of Certain Balance Sheet Accounts

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Supplemental Balance Sheet Disclosures [Text Block]

6. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consisted of the following:

	June 30, 2025		December 31, 2024
	(Amounts in Thousands)
Income tax receivable	$	3,232	$	11,568
Prepaid payroll		12,066		8,716
Prepaid workers' compensation and liability insurance		1,272		4,254
Prepaid licensing fees		5,962		5,414
Workers' compensation insurance receivable		767		810
Other (1)		8,472		7,829
Total prepaid expenses and other current assets	$	31,771	$	38,591

(1) Included $2.3 million and $6.1 million related to the New York Asset Sale deferred payments as of June 30, 2025 and December 31, 2024, respectively.

Accrued expenses consisted of the following:

	June 30, 2025		December 31, 2024
	(Amounts in Thousands)
Accrued health benefits	$	6,342	$	6,637
Accrued professional fees		7,117		5,368
Accrued payroll and other taxes		5,055		4,516
Other		14,540		12,438
Total accrued expenses	$	33,054	$	28,959

XML

Note 7 - ARPA Spending Plans

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Government Assistance [Text Block]

7. ARPA Spending Plans

To mitigate the fiscal effects of the COVID-19 public health emergency, the American Rescue Plan Act of 2021 (“ARPA”) provided for a 10-percentage point increase in federal matching funds for Medicaid home and community-based services (“HCBS”) from April 1, 2021, through March 31, 2022, provided the states satisfied certain conditions. States were generally permitted to use the state funds equivalent to the additional federal funds through March 31, 2025, but CMS granted extensions to several states, permitting some state spending plans to continue until as late as mid-2026. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021.

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses.

During the three and six months ended June 30, 2025, the Company did not receive additional state funding provided by the ARPA. Of the total state funding received by the Company pursuant to the ARPA through June 30, 2025, the Company utilized $0.8 million and $3.3 million during the three and six months ended June 30, 2025, respectively, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of June 30, 2025, the deferred portion of ARPA funding of $7.9 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

XML

Note 8 - Long-Term Debt

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Long-Term Debt [Text Block]

8. Long-Term Debt

Long-term debt consisted of the following:

	June 30, 2025			December 31, 2024
	(Amounts in Thousands)
Revolving loan under the credit facility	$	173,000		$	223,000
Less unamortized issuance costs		(3,941	)		(4,557	)
Long-term debt	$	169,059		$	218,443

Amended and Restated Senior Secured Credit Facility

On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of September 12, 2019, as further amended by the Second Amendment to Amended and Restated Credit Agreement, dated as of July 30, 2021, as further amended by the Third Amendment to Amended and Restated Credit Agreement, dated as of April 26, 2023, and as further amended by the Fourth Amendment to Amended and Restated Credit Agreement, dated as of October 22, 2024 (as described below, the “Fourth Amendment”) (as amended, the “Credit Agreement”, as used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement). The credit facility consists of a $650.0 million revolving credit facility and a $150.0 million incremental loan facility, which incremental loan facility may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is July 30, 2028.

On October 22, 2024, the Company entered into the Fourth Amendment to, among other things, (a) increase the Company’s revolving credit facility to an aggregate amount of $650.0 million, (b) increase the Company’s incremental loan facility to an aggregate amount of $150.0 million, and (c) extend the maturity date of the credit facility from July 30, 2026 to July 30, 2028.

Interest on the credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50%, and (c) the sum of Term Secured Overnight Financing Rate (“SOFR”) (as published by the CME Group Benchmark Administrative Limited) for an interest period of one month for such applicable day (not to be less than 0.00%), plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the rate per annum equal to the sum of Term SOFR (as published by the CME Group Benchmark Administrative Limited) for the applicable interest period (not to be less than 0.00%). Swing loans may not be SOFR loans.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions, and dispositions of assets. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters.

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility.

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property, and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement). The Credit Agreement also contains restrictions on guarantees, indebtedness, liens, investments, and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $10.0 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement) thresholds, restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business.

During the six months ended June 30, 2025, the Company did not draw on its credit facility and repaid $50.0 million under its revolving credit facility.

As of June 30, 2025, the Company had a total of $173.0 million of revolving loans, with an interest rate of 6.07%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $8.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $635.6 million of capacity and $454.6 million available for borrowing under its credit facility. As of December 31, 2024, the Company had a total of $223.0 million of revolving loans, with an interest rate of 6.34%, outstanding on its credit facility.

As of June 30, 2025, the Company was in compliance with all financial covenants under the Credit Agreement.

XML

Note 9 - Income Taxes

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Income Tax Disclosure [Text Block]

9. Income Taxes

The effective income tax rates were 26.4% and 26.3% for the three months ended June 30, 2025 and 2024, respectively. The effective income tax rates were 24.0% and 26.0% for the six months ended June 30, 2025 and 2024, respectively.

For the three months ended June 30, 2025, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation and an excess tax expense, partially offset by the use of federal employment tax credits. For both the three months ended June 30, 2025 and 2024, the effective tax rates were inclusive of an excess tax expense and tax benefit of 0.1%, respectively. The excess tax expense and tax benefit are discrete items, related to the vesting of equity shares, which requires the Company to recognize the expense or benefit fully in the period. An excess tax expense results if the Company’s cumulative costs of the award recognized exceed the income tax deduction, whereas an excess tax benefit results if the Company’s cumulative costs of the award recognized are less than the income tax deduction.

XML

Note 10 - Commitments and Contingencies

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]

10. Commitments and Contingencies

Legal Proceedings

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business.

It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

XML

Note 11 - Segment Information

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

11. Segment Information

Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s CODM. The Company identifies its Chief Executive Officer and Chief Operating Officer together as CODMs to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy.

The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

The CODMs do not review disaggregated assets by segment. The measure of segment assets is reported on the balance sheet as total consolidated assets.

The tables below set forth information about the Company’s reportable segments, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Unaudited Condensed Consolidated Financial Statements.

	For the Three Months Ended June 30, 2025
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	269,183	$	62,212	$	18,048	$	349,443
Direct service personnel		192,868		26,177		9,451		228,496
General and administrative salaries, wages and benefits		18,407		11,448		3,029		32,884
Other segment items 1		6,268		9,765		1,186		17,219
Segment operating income		51,640		14,822		4,382		70,844
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								34,044
Depreciation and amortization								3,913
Interest income								(583	)
Interest expense								3,525
Income before income taxes							$	29,945

(1) Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

	For the Three Months Ended June 30, 2024
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	212,817	$	56,030	$	18,075	$	286,922
Direct service personnel		152,442		23,465		10,830		186,737
General and administrative salaries, wages and benefits		11,939		9,965		3,676		25,580
Other segment items 1		5,347		9,766		1,345		16,458
Segment operating income		43,089		12,834		2,224		58,147
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								28,565
Depreciation and amortization								3,401
Interest income								(474	)
Interest expense								2,114
Income before income taxes							$	24,541

(1) Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

	For the Six Months Ended June 30, 2025
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	527,469	$	123,649	$	36,033	$	687,151
Direct service personnel		379,518		52,382		19,864		451,764
General and administrative salaries, wages and benefits		36,647		22,427		6,308		65,382
Other segment items 1		12,073		19,401		2,465		33,939
Segment operating income		99,231		29,439		7,396		136,066
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								64,809
Depreciation and amortization								7,856
Interest income								(1,085	)
Interest expense								7,543
Income before income taxes							$	56,943

(1) Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense

	For the Six Months Ended June 30, 2024
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	420,820	$	111,893	$	34,955	$	567,668
Direct service personnel		304,515		46,789		21,453		372,757
General and administrative salaries, wages and benefits		23,099		20,043		7,339		50,481
Other segment items 1		10,095		18,770		2,662		31,527
Segment operating income		83,111		26,291		3,501		112,903
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								56,207
Depreciation and amortization								6,870
Interest income								(897	)
Interest expense								4,872
Income before income taxes							$	45,851

(1) Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense

XML

Note 12 - Significant Payors

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Concentration Risk Disclosure [Text Block]

12. Significant Payors

The Company’s revenue by payor type was as follows:

Personal Care Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
State, local and other governmental programs	$	138,506		51.4	%	$	113,002		53.1	%	$	271,410		51.4	%	$	220,756		52.5	%
Managed care organizations		121,900		45.3			94,135		44.2			238,907		45.3			188,411		44.8
Private pay		7,292		2.7			3,689		1.7			14,268		2.7			7,595		1.8
Commercial insurance		1,334		0.5			1,467		0.7			2,494		0.5			2,953		0.7
Other		151		0.1			524		0.3			390		0.1			1,105		0.2
Total personal care segment net service revenues	$	269,183		100.0	%	$	212,817		100.0	%	$	527,469		100.0	%	$	420,820		100.0	%

Hospice Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Medicare	$	57,846		93.0	%	$	51,122		91.2	%	$	114,638		92.7	%	$	101,774		91.0	%
Commercial insurance		1,997		3.2			2,844		5.1			4,375		3.5			5,978		5.3
Managed care organizations		2,001		3.2			1,880		3.4			4,029		3.3			3,697		3.3
Other		368		0.6			184		0.3			607		0.5			444		0.4
Total hospice segment net service revenues	$	62,212		100.0	%	$	56,030		100.0	%	$	123,649		100.0	%	$	111,893		100.0	%

Home Health Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Medicare	$	12,517		69.4	%	$	12,517		69.3	%	$	25,094		69.7	%	$	24,180		69.2	%
Managed care organizations		4,264		23.6			4,676		25.9			8,072		22.4			9,076		26.0
State, local and other governmental programs (excluding Medicare)		796		4.4			44		0.2			1,884		5.2			70		0.2
Other		471		2.6			838		4.6			983		2.7			1,629		4.6
Total home health segment net service revenues	$	18,048		100.0	%	$	18,075		100.0	%	$	36,033		100.0	%	$	34,955		100.0	%

The Company derives a significant amount of its revenue from its operations in Illinois, New Mexico, Ohio, Tennessee, and Texas. The percentages of segment revenue for each of these significant states and New York for the three and six months ended June 30, 2025 and 2024, respectively, were as follows:

Personal Care Segment	For the Three Months Ended June 30,											For the Six Months Ended June 30,
	2025						2024					2025					2024
				% of Segment					% of Segment					% of Segment					% of Segment
	Amount			Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)			Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Illinois	$	115,226			42.8	%	$	110,774		52.1	%	$	226,640		43.0	%	$	218,349		51.9	%
New Mexico		28,987			10.8			28,644		13.5			57,292		10.9			57,611		13.7
New York(1)		(59	)		—			23,299		10.9			214		—			46,833		11.1
Texas		52,464			19.5			—		—			102,324		19.4			—		—
All other states		72,565			26.9			50,100		23.5			140,999		26.7			98,027		23.3
Total personal care segment net service revenues	$	269,183			100.0	%	$	212,817		100.0	%	$	527,469		100.0	%	$	420,820		100.0	%

(1) As a result of changes and uncertainty in New York regarding the CDPAP, the Company determined that its New York personal care operations no longer fit its growth strategy and is divesting these operations. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture.

Hospice Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Ohio	$	23,204		37.3	%	$	20,633		36.8	%	$	46,391		37.5	%	$	40,869		36.5	%
Illinois		14,419		23.2			13,003		23.2			28,983		23.4			25,255		22.6
New Mexico		8,184		13.2			6,895		12.3			16,097		13.0			14,410		12.9
All other states		16,405		26.3			15,499		27.7			32,178		26.1			31,359		28.0
Total hospice segment net service revenues	$	62,212		100.0	%	$	56,030		100.0	%	$	123,649		100.0	%	$	111,893		100.0	%

Home Health Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
New Mexico	$	8,737		48.4	%	$	8,300		45.9	%	$	17,292		48.0	%	$	16,077		46.0	%
Illinois		1,989		11.0			3,042		16.8			3,921		10.9			5,984		17.1
Tennessee		7,322		40.6			6,733		37.3			14,820		41.1			12,894		36.9
Total home health segment net service revenues	$	18,048		100.0	%	$	18,075		100.0	%	$	36,033		100.0	%	$	34,955		100.0	%

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state, and local governmental agencies. The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 33.0% and 38.6% of our net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 33.0% and 38.5% of our net service revenues for the six months ended June 30, 2025 and 2024, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 18.6% and 21.1% of the Company’s net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 18.6% and 20.9% of the Company’s net service revenues for the six months ended June 30, 2025 and 2024, respectively.

The related receivables due from the Illinois Department on Aging represented 19.0% and 21.7% of the Company’s net accounts receivable at  June 30, 2025 and December 31, 2024, respectively.

XML

Note 13 - Subsequent Events

6 Months Ended

Jun. 30, 2025

Notes to Financial Statements

Subsequent Events [Text Block]

13. Subsequent Events

On August 1, 2025, the Company completed the acquisition of Helping Hands Home Care Service, Inc., a Pennsylvania corporation (“Helping Hands”), for approximately $21.3 million. The purchase was funded through the Company’s revolving credit facility and available cash. With the purchase of Helping Hands, the Company expanded its services within its personal care segment and entered the hospice and home health markets in Pennsylvania. The initial accounting is not yet complete, and therefore the related business combination disclosures have not been presented as the Company is currently in the process of valuing the assets acquired and liabilities assumed in the transaction.

On July 4, 2025, H.R. 1, commonly known as the “One Big Beautiful Bill Act” (the “OBBBA”), was enacted into law. The OBBBA includes several provisions, including the permanent extension of several business tax benefits originally introduced under the 2017 Tax Cuts and Jobs Act. The Company is currently evaluating the impact of the legislation on its condensed consolidated financial statements.

XML

Insider Trading Arrangements

3 Months Ended

6 Months Ended

Jun. 30, 2025

Jun. 30, 2025

Trading Arrangements, by Individual [Table]

Material Terms of Trading Arrangement [Text Block]

Item 5.         Other Information

Not applicable. Without limiting the generality of the foregoing, during the quarter ended June 30, 2025, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements, as such terms are defined in Item 408(a) of Regulation S-K.

Rule 10b5-1 Arrangement Terminated [Flag]

false

Rule 10b5-1 Arrangement Adopted [Flag]

false

Non-Rule 10b5-1 Arrangement Terminated [Flag]

false

Non-Rule 10b5-1 Arrangement Adopted [Flag]

false

XML

Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2025

Accounting Policies [Abstract]

Use of Estimates, Policy [Policy Text Block]

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles and business combinations, and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.

Earnings Per Share, Policy [Policy Text Block]

Computation of Weighted Average Shares

The following table sets forth the computation of basic and diluted common shares:

	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	(Amounts in thousands)				(Amounts in thousands)
	2025		2024		2025		2024
Weighted average number of shares outstanding for basic per share calculation		18,045		16,177		18,011		16,120
Effect of dilutive potential shares:
Stock options		219		251		221		239
Restricted stock awards		68		70		108		90
Adjusted weighted average shares for diluted per share calculation		18,332		16,498		18,340		16,449
Anti-dilutive shares:
Stock options		—		19		—		42
Restricted stock awards		9		8		9		8

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Adopted Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Improvements to Reportable Segment Disclosures, which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require, among other things, disclosure of significant segment expenses that are regularly provided to an entity’s chief operating decision maker (“CODM”) and a description of other segment items (the difference between segment revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss) by reportable segment, as well as disclosure of the title and position of the CODM, and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The ASU was adopted in connection with the Company's most recent Annual Report on Form 10-K, which included significant segment expenses reviewed by the Company’s CODM, but did not have a material impact on the Company’s results of operations, financial position, or cash flows.

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, may be applied on a prospective basis with the option to apply the standard retrospectively, and allows for early adoption. These requirements are not expected to have a material impact on the Company’s financial statements and will expand income tax disclosures.

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which intends to provide investors more detailed disclosures around specific types of expenses. The new disclosures require certain details for expenses presented on the face of the Consolidated Statements of Operations as well as selling expenses to be presented in the notes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. The Company is currently assessing the impact and timing of adopting the updated provisions.

XML

Note 2 - Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2025

Notes Tables

Schedule of Weighted Average Number of Shares [Table Text Block]

	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	(Amounts in thousands)				(Amounts in thousands)
	2025		2024		2025		2024
Weighted average number of shares outstanding for basic per share calculation		18,045		16,177		18,011		16,120
Effect of dilutive potential shares:
Stock options		219		251		221		239
Restricted stock awards		68		70		108		90
Adjusted weighted average shares for diluted per share calculation		18,332		16,498		18,340		16,449
Anti-dilutive shares:
Stock options		—		19		—		42
Restricted stock awards		9		8		9		8

XML

Note 3 - Divesture (Tables)

6 Months Ended

Jun. 30, 2025

Notes Tables

Disposal Groups, Including Discontinued Operations [Table Text Block]

	June 30, 2025
Assets
Current assets
Accounts receivable, net of allowances	$	—
Prepaid expenses and other current assets		11
Total current assets		11
Property and equipment, net of accumulated depreciation and amortization		—
Other assets
Goodwill		—
Intangibles, net of accumulated amortization		—
Operating lease assets, net		2,910
Total other assets		2,910
Total assets	$	2,921
Liabilities
Current liabilities
Accounts payable	$	1,064
Accrued payroll		8
Accrued expenses		599
Operating lease liabilities, current portion		642
Total current liabilities		2,313
Long-term liabilities
Operating lease liabilities, long-term portion		2,187
Total liabilities	$	4,500

XML

Note 4 - Leases (Tables)

6 Months Ended

Jun. 30, 2025

Notes Tables

Schedule Of Balance Sheet Information, Related To Operating Leases [Table Text Block]

	June 30, 2025		December 31, 2024
	(Amounts in Thousands)
Operating lease assets, net	$	45,965	$	47,348
Short-term operating lease liabilities		12,969		12,800
Long-term operating lease liabilities		40,223		41,883
Total operating lease liabilities	$	53,192	$	54,683

Lease, Cost [Table Text Block]

	For the Three Months Ended June 30,					For the Six Months Ended June 30,
	(Amounts in Thousands)					(Amounts in Thousands)
	2025		2024			2025			2024
Operating lease costs	$	3,651	$	3,373		$	7,308		$	6,669
Short-term lease costs		271		179			555			380
Total lease costs		3,922		3,552			7,863			7,049
Less: sublease income		—		(491	)		(226	)		(1,089	)
Total lease costs, net	$	3,922	$	3,061		$	7,637		$	5,960

Schedule of Lease Term and Discount Rate [Table Text Block]

	June 30, 2025			December 31, 2024
Operating leases:
Weighted average remaining lease term		5.37			5.48
Weighted average discount rate		6.32	%		6.20	%

Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]

	Operating Leases
	(Amounts in Thousands)
Due in the 12-month period ended June 30,
2026	$	15,739
2027		12,746
2028		9,459
2029		6,946
2030		6,200
Thereafter		12,311
Total future minimum rental commitments		63,401
Less: Imputed interest		(10,209	)
Total lease liabilities	$	53,192

Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]

	For the Six Months Ended June 30,
	(Amounts in Thousands)
	2025		2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	8,368	$	7,224
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	5,158	$	4,509

XML

Note 5 - Goodwill and Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2025

Notes Tables

Schedule of Goodwill [Table Text Block]

						Home
	Hospice		Personal Care			Health			Total
	(Amounts in Thousands)
Goodwill as of December 31, 2024	$	432,840	$	442,526		$	95,192		$	970,558
Additions for acquisitions		—		3,350			—			3,350
Adjustments to previously recorded goodwill		26		(3,768	)		(342	)		(4,084	)
Goodwill as of June 30, 2025	$	432,866	$	442,108		$	94,850		$	969,824

Schedule of Finite-Lived Intangible Assets [Table Text Block]

		June 30, 2025							December 31, 2024
		(Amounts in Thousands)							(Amounts in Thousands)
	Estimated Useful	Gross		Accumulated			Net		Gross		Accumulated			Net
	Life (years)	carrying value		amortization			carrying value		carrying value		amortization			carrying value
Customer and referral relationships	3 - 15	$	34,201	$	(33,461	)	$	740	$	34,201	$	(33,255	)	$	946
Trade names and trademarks	1 - 20		59,366		(24,217	)		35,149		59,366		(21,900	)		37,466
Non-competition agreement	3 - 5		6,728		(6,476	)		252		6,728		(6,263	)		465
State Licenses	6 - 10		24,981		(2,494	)		22,487		24,981		(1,243	)		23,738
State Licenses	Indefinite		47,028		—			47,028		47,028		—			47,028
Total intangible assets		$	172,304	$	(66,648	)	$	105,656	$	172,304	$	(62,661	)	$	109,643

XML

Note 6 - Details of Certain Balance Sheet Accounts (Tables)

6 Months Ended

Jun. 30, 2025

Notes Tables

Schedule of Other Current Assets [Table Text Block]

	June 30, 2025		December 31, 2024
	(Amounts in Thousands)
Income tax receivable	$	3,232	$	11,568
Prepaid payroll		12,066		8,716
Prepaid workers' compensation and liability insurance		1,272		4,254
Prepaid licensing fees		5,962		5,414
Workers' compensation insurance receivable		767		810
Other (1)		8,472		7,829
Total prepaid expenses and other current assets	$	31,771	$	38,591

Schedule of Accrued Liabilities [Table Text Block]

	June 30, 2025		December 31, 2024
	(Amounts in Thousands)
Accrued health benefits	$	6,342	$	6,637
Accrued professional fees		7,117		5,368
Accrued payroll and other taxes		5,055		4,516
Other		14,540		12,438
Total accrued expenses	$	33,054	$	28,959

XML

Note 8 - Long-Term Debt (Tables)

6 Months Ended

Jun. 30, 2025

Notes Tables

Schedule of Long-Term Debt Instruments [Table Text Block]

	June 30, 2025			December 31, 2024
	(Amounts in Thousands)
Revolving loan under the credit facility	$	173,000		$	223,000
Less unamortized issuance costs		(3,941	)		(4,557	)
Long-term debt	$	169,059		$	218,443

XML

Note 11 - Segment Information (Tables)

6 Months Ended

Jun. 30, 2025

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	For the Three Months Ended June 30, 2025
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	269,183	$	62,212	$	18,048	$	349,443
Direct service personnel		192,868		26,177		9,451		228,496
General and administrative salaries, wages and benefits		18,407		11,448		3,029		32,884
Other segment items 1		6,268		9,765		1,186		17,219
Segment operating income		51,640		14,822		4,382		70,844
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								34,044
Depreciation and amortization								3,913
Interest income								(583	)
Interest expense								3,525
Income before income taxes							$	29,945

	For the Three Months Ended June 30, 2024
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	212,817	$	56,030	$	18,075	$	286,922
Direct service personnel		152,442		23,465		10,830		186,737
General and administrative salaries, wages and benefits		11,939		9,965		3,676		25,580
Other segment items 1		5,347		9,766		1,345		16,458
Segment operating income		43,089		12,834		2,224		58,147
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								28,565
Depreciation and amortization								3,401
Interest income								(474	)
Interest expense								2,114
Income before income taxes							$	24,541

	For the Six Months Ended June 30, 2025
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	527,469	$	123,649	$	36,033	$	687,151
Direct service personnel		379,518		52,382		19,864		451,764
General and administrative salaries, wages and benefits		36,647		22,427		6,308		65,382
Other segment items 1		12,073		19,401		2,465		33,939
Segment operating income		99,231		29,439		7,396		136,066
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								64,809
Depreciation and amortization								7,856
Interest income								(1,085	)
Interest expense								7,543
Income before income taxes							$	56,943

	For the Six Months Ended June 30, 2024
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	420,820	$	111,893	$	34,955	$	567,668
Direct service personnel		304,515		46,789		21,453		372,757
General and administrative salaries, wages and benefits		23,099		20,043		7,339		50,481
Other segment items 1		10,095		18,770		2,662		31,527
Segment operating income		83,111		26,291		3,501		112,903
Segment reconciliation:
Items not allocated at segment level:
Other general and administrative expenses								56,207
Depreciation and amortization								6,870
Interest income								(897	)
Interest expense								4,872
Income before income taxes							$	45,851

XML

Note 12 - Significant Payors (Tables)

6 Months Ended

Jun. 30, 2025

Notes Tables

Revenue from External Customers by Products and Services [Table Text Block]

Personal Care Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
State, local and other governmental programs	$	138,506		51.4	%	$	113,002		53.1	%	$	271,410		51.4	%	$	220,756		52.5	%
Managed care organizations		121,900		45.3			94,135		44.2			238,907		45.3			188,411		44.8
Private pay		7,292		2.7			3,689		1.7			14,268		2.7			7,595		1.8
Commercial insurance		1,334		0.5			1,467		0.7			2,494		0.5			2,953		0.7
Other		151		0.1			524		0.3			390		0.1			1,105		0.2
Total personal care segment net service revenues	$	269,183		100.0	%	$	212,817		100.0	%	$	527,469		100.0	%	$	420,820		100.0	%

Hospice Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Medicare	$	57,846		93.0	%	$	51,122		91.2	%	$	114,638		92.7	%	$	101,774		91.0	%
Commercial insurance		1,997		3.2			2,844		5.1			4,375		3.5			5,978		5.3
Managed care organizations		2,001		3.2			1,880		3.4			4,029		3.3			3,697		3.3
Other		368		0.6			184		0.3			607		0.5			444		0.4
Total hospice segment net service revenues	$	62,212		100.0	%	$	56,030		100.0	%	$	123,649		100.0	%	$	111,893		100.0	%

Home Health Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Medicare	$	12,517		69.4	%	$	12,517		69.3	%	$	25,094		69.7	%	$	24,180		69.2	%
Managed care organizations		4,264		23.6			4,676		25.9			8,072		22.4			9,076		26.0
State, local and other governmental programs (excluding Medicare)		796		4.4			44		0.2			1,884		5.2			70		0.2
Other		471		2.6			838		4.6			983		2.7			1,629		4.6
Total home health segment net service revenues	$	18,048		100.0	%	$	18,075		100.0	%	$	36,033		100.0	%	$	34,955		100.0	%

Personal Care Segment	For the Three Months Ended June 30,											For the Six Months Ended June 30,
	2025						2024					2025					2024
				% of Segment					% of Segment					% of Segment					% of Segment
	Amount			Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)			Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Illinois	$	115,226			42.8	%	$	110,774		52.1	%	$	226,640		43.0	%	$	218,349		51.9	%
New Mexico		28,987			10.8			28,644		13.5			57,292		10.9			57,611		13.7
New York(1)		(59	)		—			23,299		10.9			214		—			46,833		11.1
Texas		52,464			19.5			—		—			102,324		19.4			—		—
All other states		72,565			26.9			50,100		23.5			140,999		26.7			98,027		23.3
Total personal care segment net service revenues	$	269,183			100.0	%	$	212,817		100.0	%	$	527,469		100.0	%	$	420,820		100.0	%

Hospice Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
Ohio	$	23,204		37.3	%	$	20,633		36.8	%	$	46,391		37.5	%	$	40,869		36.5	%
Illinois		14,419		23.2			13,003		23.2			28,983		23.4			25,255		22.6
New Mexico		8,184		13.2			6,895		12.3			16,097		13.0			14,410		12.9
All other states		16,405		26.3			15,499		27.7			32,178		26.1			31,359		28.0
Total hospice segment net service revenues	$	62,212		100.0	%	$	56,030		100.0	%	$	123,649		100.0	%	$	111,893		100.0	%

Home Health Segment	For the Three Months Ended June 30,										For the Six Months Ended June 30,
	2025					2024					2025					2024
			% of Segment					% of Segment					% of Segment					% of Segment
	Amount		Net Service			Amount		Net Service			Amount		Net Service			Amount		Net Service
	(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues			(in Thousands)		Revenues
New Mexico	$	8,737		48.4	%	$	8,300		45.9	%	$	17,292		48.0	%	$	16,077		46.0	%
Illinois		1,989		11.0			3,042		16.8			3,921		10.9			5,984		17.1
Tennessee		7,322		40.6			6,733		37.3			14,820		41.1			12,894		36.9
Total home health segment net service revenues	$	18,048		100.0	%	$	18,075		100.0	%	$	36,033		100.0	%	$	34,955		100.0	%

XML

Note 1 - Nature of Operations, Consolidation, and Presentation of Financial Statements (Details Textual)	6 Months Ended
	Jun. 30, 2025
Number of Operating Segments	3

XML

Note 2 - Summary of Significant Accounting Policies - Schedule of Weighted Average Number of Shares (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Basic (in shares)	18,045	16,177	18,011	16,120
Diluted (in shares)	18,332	16,498	18,340	16,449
Share-Based Payment Arrangement, Option [Member]
Stock options (in shares)	219	251	221	239
Stock options, Anti-dilutive (in shares)	0	19	0	42
Restricted stock awards (in shares)	0	19	0	42
Restricted Stock [Member]
Stock options (in shares)	68	70	108	90
Stock options, Anti-dilutive (in shares)	9	8	9	8
Restricted stock awards (in shares)	9	8	9	8

XML

Note 3 - Divesture (Details Textual) - USD ($) $ in Thousands		1 Months Ended	6 Months Ended		12 Months Ended
	May 20, 2024	Oct. 31, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Proceeds from Divestiture of Businesses			$ 3,848	$ 4,600
New York Asset Sale [Member]
Disposal Group, Including Discontinued Operation, Consideration	$ 23,000
Disposal Group, Including Discontinued Operation, Cash Consideration, Percent	50.00%
Proceeds from Divestiture of Businesses	$ 4,600
Disposal Group, Including Discontinued Operation, Consideration Receivable Debt	$ 6,900		2,300
Disposal Group, Including Discontinued Operation, Contingent Consideration, Percent	50.00%
Divesture of Businesses, Consideration Transferred, Percentage		50.00%
Gain (Loss) on Disposition of Business					$ 3,700
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent			2,900
Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent			4,200
New York Asset Sale [Member] | Deferred Payments [Member]
Proceeds from Divestiture of Businesses			$ 3,800

XML

Note 3 - Divesture - Schedule of Discontinued Operations (Details) - New York Personal Care Operations [Member] $ in Thousands	Jun. 30, 2025 USD ($)
Accounts receivable, net of allowances	$ 0
Prepaid expenses and other current assets	11
Total current assets	11
Property and equipment, net of accumulated depreciation and amortization	0
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent	0
Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent	0
Operating lease assets, net	2,910
Total other assets	2,910
Total assets	2,921
Accounts payable	1,064
Accrued payroll	8
Accrued expenses	599
Operating lease liabilities, current portion	642
Total current liabilities	2,313
Operating lease liabilities, long-term portion	2,187
Total liabilities	$ 4,500

XML

Note 4 - Leases - Schedule Of Balance Sheet Information, Related To Operating Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Operating lease assets, net	$ 45,965	$ 47,348
Short-term operating lease liabilities	12,969	12,800
Long-term operating lease liabilities	40,223	41,883
Total operating lease liabilities	$ 53,192	$ 54,683

XML

Note 4 - Leases - Schedule of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating lease costs	$ 3,651	$ 3,373	$ 7,308	$ 6,669
Short-term lease costs	271	179	555	380
Total lease costs	3,922	3,552	7,863	7,049
Less: sublease income	0	(491)	(226)	(1,089)
Total lease costs, net	$ 3,922	$ 3,061	$ 7,637	$ 5,960

XML

Note 4 - Leases - Lease Term and Discount Rate (Details)	Jun. 30, 2025	Dec. 31, 2024
Weighted average remaining lease term (Year)	5 years 4 months 13 days	5 years 5 months 23 days
Weighted average discount rate	6.32%	6.20%

XML

Note 4 - Leases - Schedule of Operating Lease Liability Maturities (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
2026	$ 15,739
2027	12,746
2028	9,459
2029	6,946
2030	6,200
Thereafter	12,311
Total future minimum rental commitments	63,401
Less: Imputed interest	(10,209)
Total lease liabilities	$ 53,192	$ 54,683

XML

Note 4 - Leases - Schedule of Cash Flow, Supplemental Disclosures (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Operating cash flows from operating leases	$ 8,368	$ 7,224
Operating leases	$ 5,158	$ 4,509

XML

Note 5 - Goodwill and Intangible Assets (Details Textual) - USD ($) $ in Thousands			3 Months Ended		6 Months Ended
	Mar. 01, 2025	Jan. 01, 2025	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Mar. 31, 2025	Dec. 31, 2024
Goodwill			$ 969,824		$ 969,824			$ 970,558
Goodwill, Measurement Period Adjustment			(2,500)		(4,084)
Amortization of Intangible Assets			$ 2,000	$ 1,800	$ 4,000	$ 3,600
Finite-Lived Intangible Assets, Remaining Amortization Period (Year)			9 years 5 months 12 days		9 years 5 months 12 days
Proceeds from Previous Acquisition					$ 2,937	$ 0
Minimum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)			1 year		1 year
Minimum [Member] | Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life (Year)			3 years		3 years
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)			20 years		20 years
Maximum [Member] | Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life (Year)			15 years		15 years
Personal Care Segment [Member]
Goodwill			$ 442,108		$ 442,108			$ 442,526
Goodwill, Measurement Period Adjustment					(3,768)
Jacksonville Affiliate [Member]
Business Combination, Consideration Transferred		$ 800
Jacksonville Affiliate [Member] | Personal Care Segment [Member]
Goodwill		$ 800
Great Lakes Home Care Unlimited, LLC [Member]
Business Combination, Consideration Transferred	$ 2,600
Great Lakes Home Care Unlimited, LLC [Member] | Personal Care Segment [Member]
Goodwill							$ 2,600
Gentiva Acquisition [Member]
Proceeds from Previous Acquisition					$ 2,900

XML

Note 5 - Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2025
Goodwill, Balance		$ 970,558
Additions for acquisitions		3,350
Adjustments to previously recorded goodwill	$ (2,500)	(4,084)
Goodwill, Balance	969,824	969,824
Hospice Segment [Member]
Goodwill, Balance		432,840
Additions for acquisitions		0
Adjustments to previously recorded goodwill		26
Goodwill, Balance	432,866	432,866
Personal Care Segment [Member]
Goodwill, Balance		442,526
Additions for acquisitions		3,350
Adjustments to previously recorded goodwill		(3,768)
Goodwill, Balance	442,108	442,108
Home Health Segment [Member]
Goodwill, Balance		95,192
Additions for acquisitions		0
Adjustments to previously recorded goodwill		(342)
Goodwill, Balance	$ 94,850	$ 94,850

XML

Note 5 - Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Finite-Lived Intangible Assets, Accumulated Amortization	$ (66,648)	$ (62,661)
Total intangible assets	172,304	172,304
Total intangible assets	105,656	109,643
State Licensing Agreements [Member]
Indefinite-Lived Intangible Assets (Excluding Goodwill), Gross	$ 47,028	47,028
Minimum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	1 year
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	20 years
Customer Relationships [Member]
Finite-Lived Intangible Assets, Gross	$ 34,201	34,201
Finite-Lived Intangible Assets, Accumulated Amortization	(33,461)	(33,255)
Finite-Lived Intangible Assets, Net	$ 740	946
Customer Relationships [Member] | Minimum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	3 years
Customer Relationships [Member] | Maximum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	15 years
Trademarks and Trade Names [Member]
Finite-Lived Intangible Assets, Gross	$ 59,366	59,366
Finite-Lived Intangible Assets, Accumulated Amortization	(24,217)	(21,900)
Finite-Lived Intangible Assets, Net	$ 35,149	37,466
Trademarks and Trade Names [Member] | Minimum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	1 year
Trademarks and Trade Names [Member] | Maximum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	20 years
Noncompete Agreements [Member]
Finite-Lived Intangible Assets, Gross	$ 6,728	6,728
Finite-Lived Intangible Assets, Accumulated Amortization	(6,476)	(6,263)
Finite-Lived Intangible Assets, Net	$ 252	465
Noncompete Agreements [Member] | Minimum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	3 years
Noncompete Agreements [Member] | Maximum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	5 years
Licensing Agreements [Member]
Finite-Lived Intangible Assets, Gross	$ 24,981	24,981
Finite-Lived Intangible Assets, Accumulated Amortization	(2,494)	(1,243)
Finite-Lived Intangible Assets, Net	$ 22,487	$ 23,738
Licensing Agreements [Member] | Minimum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	6 years
Licensing Agreements [Member] | Maximum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	10 years

XML

Note 6 - Details of Certain Balance Sheet Accounts (Details Textual) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
New York Asset Sale [Member]
Disposal Group, Including Discontinued Operation, Consideration Receivable Debt	$ 2.3	$ 6.1

XML

Note 6 - Details of Certain Balance Sheet Accounts - Schedule of Other Current Assets (Details) - USD ($) $ in Thousands		Jun. 30, 2025	Dec. 31, 2024
Income tax receivable		$ 3,232	$ 11,568
Prepaid payroll		12,066	8,716
Prepaid workers' compensation and liability insurance		1,272	4,254
Prepaid licensing fees		5,962	5,414
Workers' compensation insurance receivable		767	810
Other (1)	[1]	8,472	7,829
Total prepaid expenses and other current assets		$ 31,771	$ 38,591

[1] Included $2.3 million and $6.1 million related to the New York Asset Sale deferred payments as of March 31, 2025 and December 31, 2024, respectively.

XML

Note 6 - Details of Certain Balance Sheet Accounts - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Accrued health benefits	$ 6,342	$ 6,637
Accrued professional fees	7,117	5,368
Accrued payroll and other taxes	5,055	4,516
Other	14,540	12,438
Total accrued expenses	$ 33,054	$ 28,959

XML

Note 7 - ARPA Spending Plans (Details Textual) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2025	Dec. 31, 2024
Government Assistance, Liability, Current	$ 7,927	$ 7,927	$ 11,239
ARPA Spending Plans [Member]
Government Assistance, Liability, Increase, Current	0	0
Government Assistance, Operating Expense, Decrease (Increase)	3,300	800
Government Assistance, Liability, Current	$ 7,900	$ 7,900

XML

Note 8 - Long-Term Debt (Details Textual) $ in Thousands			6 Months Ended
	Oct. 22, 2024 USD ($)	Apr. 26, 2023	Jun. 30, 2025 USD ($)	Jun. 30, 2024 USD ($)	Dec. 31, 2024 USD ($)
Repayments of Lines of Credit			$ 50,000	$ 126,353
Credit Agreement [Member]
Debt Instrument, Face Amount	$ 150,000
Debt Instrument, Maturity Date	Jul. 30, 2028	Jul. 30, 2028
Credit Agreement [Member] | Minimum [Member]
Debt Instrument, Interest Rate, Effective Percentage	0.00%
Credit Agreement [Member] | Minimum [Member] | Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument, Basis Spread on Variable Rate	1.75%
Credit Agreement [Member] | Maximum [Member] | Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument, Basis Spread on Variable Rate	2.50%
Revolving Credit Facility [Member] | Credit Agreement [Member]
Long-Term Line of Credit			635,600
Line of Credit Facility, Remaining Borrowing Capacity			454,600
Capital One, National Association [Member] | Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity			$ 650,000
Line of Credit, Net Leverage Ratio	3.75		4.25
Debt Instrument, Covenant, Maximus Distribution Amount			$ 10,000
Repayments of Lines of Credit			50,000
Long-Term Line of Credit			$ 173,000		$ 223,000
Debt Instrument, Interest Rate, Stated Percentage			6.07%		6.34%
Lines of Credit, Outstanding Limits			$ 8,000
Proceeds from Lines of Credit			$ 0
Capital One, National Association [Member] | Revolving Credit Facility [Member] | Federal Funds Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Capital One, National Association [Member] | Revolving Credit Facility [Member] | Minimum [Member]
Debt Instrument, Interest Rate, Effective Percentage	0.00%
Debt Instrument, Leverage Ratio Fee, Percent	0.20%
Capital One, National Association [Member] | Revolving Credit Facility [Member] | Minimum [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	0.75%
Capital One, National Association [Member] | Revolving Credit Facility [Member] | Maximum [Member]
Debt Instrument, Leverage Ratio Fee, Percent	0.35%
Capital One, National Association [Member] | Revolving Credit Facility [Member] | Maximum [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	1.50%
Capital One, National Association [Member] | Revolving Credit Facility [Member] | Weighted Average [Member] | Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument, Interest Rate, Effective Percentage	1.00%

XML

Note 8 - Long-Term Debt - Schedule of Debt Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Less unamortized issuance costs	$ (3,941)	$ (4,557)
Long-term debt	169,059	218,443
Capital One, National Association [Member] | Revolving Credit Facility [Member]
Revolving loan under the credit facility	$ 173,000	$ 223,000

XML

Note 9 - Income Taxes (Details Textual)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Effective Income Tax Rate Reconciliation, Percent	26.40%	26.30%	24.00%	26.00%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent	0.10%	0.10%

XML

Note 11 - Segment Information (Details Textual)	6 Months Ended
	Jun. 30, 2025
Number of Operating Segments	3
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]	Chief Executive Officer [Member]
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description	The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

XML

Note 11 - Segment Information - Schedule of Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2025		Jun. 30, 2024		Jun. 30, 2025		Jun. 30, 2024
Net service revenues	$ 349,443		$ 286,922		$ 687,151		$ 567,668
Operating income	32,887		26,181		63,401		49,826
Depreciation and amortization	3,913		3,401		7,856		6,870
Interest income	(583)		(474)		(1,085)		(897)
Interest expense	3,525		2,114		7,543		4,872
Operating Segments [Member]
Net service revenues	349,443		286,922		687,151		567,668
Other segment items 1	17,219	[1]	16,458	[1]	33,939	[2]	31,527	[2]
Operating income	70,844		58,147		136,066		112,903
Other general and administrative expenses	34,044		28,565		64,809		56,207
Depreciation and amortization	3,913		3,401		7,856		6,870
Interest income	(583)		(474)		(1,085)		(897)
Interest expense	3,525		2,114		7,543		4,872
Income before income taxes	29,945		24,541		56,943		45,851
Operating Segments [Member] | Cost of Sales [Member]
Labor and Related Expense	228,496		186,737		451,764		372,757
Operating Segments [Member] | General and Administrative Expense [Member]
Labor and Related Expense	32,884		25,580		65,382		50,481
Operating Segments [Member] | Personal Care [Member]
Net service revenues	269,183		212,817		527,469		420,820
Other segment items 1	6,268	[1]	5,347	[1]	12,073	[2]	10,095	[2]
Operating income	51,640		43,089		99,231		83,111
Operating Segments [Member] | Personal Care [Member] | Cost of Sales [Member]
Labor and Related Expense	192,868		152,442		379,518		304,515
Operating Segments [Member] | Personal Care [Member] | General and Administrative Expense [Member]
Labor and Related Expense	18,407		11,939		36,647		23,099
Operating Segments [Member] | Hospice [Member]
Net service revenues	62,212		56,030		123,649		111,893
Other segment items 1	9,765	[1]	9,766	[1]	19,401	[2]	18,770	[2]
Operating income	14,822		12,834		29,439		26,291
Operating Segments [Member] | Hospice [Member] | Cost of Sales [Member]
Labor and Related Expense	26,177		23,465		52,382		46,789
Operating Segments [Member] | Hospice [Member] | General and Administrative Expense [Member]
Labor and Related Expense	11,448		9,965		22,427		20,043
Operating Segments [Member] | Home Health [Member]
Net service revenues	18,048		18,075		36,033		34,955
Other segment items 1	1,186	[1]	1,345	[1]	2,465	[2]	2,662	[2]
Operating income	4,382		2,224		7,396		3,501
Operating Segments [Member] | Home Health [Member] | Cost of Sales [Member]
Labor and Related Expense	9,451		10,830		19,864		21,453
Operating Segments [Member] | Home Health [Member] | General and Administrative Expense [Member]
Labor and Related Expense	$ 3,029		$ 3,676		$ 6,308		$ 7,339

[1] Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

[2] Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense

XML

Note 12 - Significant Payors (Details Textual) - ILLINOIS	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Geographic Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member]
Concentration Risk, Percentage	33.00%	38.60%	33.00%	38.50%
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member]
Concentration Risk, Percentage	18.60%	21.10%	18.60%	20.90%
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage			19.00%		21.70%

XML

Note 12 - Significant Payors - Revenue from External Customers by Products and Services (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Net service revenues		$ 349,443	$ 286,922	$ 687,151	$ 567,668
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member]
Net service revenues		$ 62,212	$ 56,030	$ 123,649	$ 111,893
Concentration Risk, Percentage		100.00%	100.00%	100.00%	100.00%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | Medicare [Member]
Net service revenues		$ 57,846	$ 51,122	$ 114,638	$ 101,774
Concentration Risk, Percentage		93.00%	91.20%	92.70%	91.00%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | Commercial Insurance [Member]
Net service revenues		$ 1,997	$ 2,844	$ 4,375	$ 5,978
Concentration Risk, Percentage		3.20%	5.10%	3.50%	5.30%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | Managed Care Organizations [Member]
Net service revenues		$ 2,001	$ 1,880	$ 4,029	$ 3,697
Concentration Risk, Percentage		3.20%	3.40%	3.30%	3.30%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | Other [Member]
Net service revenues		$ 368	$ 184	$ 607	$ 444
Concentration Risk, Percentage		0.60%	0.30%	0.50%	0.40%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member]
Net service revenues		$ 18,048	$ 18,075	$ 36,033	$ 34,955
Concentration Risk, Percentage		100.00%	100.00%	100.00%	100.00%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | Medicare [Member]
Net service revenues		$ 12,517	$ 12,517	$ 25,094	$ 24,180
Concentration Risk, Percentage		69.40%	69.30%	69.70%	69.20%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | Managed Care Organizations [Member]
Net service revenues		$ 4,264	$ 4,676	$ 8,072	$ 9,076
Concentration Risk, Percentage		23.60%	25.90%	22.40%	26.00%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | State, Local, and Other Governmental Programs (Excluding Medicare) [Member]
Net service revenues		$ 796	$ 44	$ 1,884	$ 70
Concentration Risk, Percentage		4.40%	0.20%	5.20%	0.20%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | Other [Member]
Net service revenues		$ 471	$ 838	$ 983	$ 1,629
Concentration Risk, Percentage		2.60%	4.60%	2.70%	4.60%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member]
Net service revenues		$ 269,183	$ 212,817	$ 527,469	$ 420,820
Concentration Risk, Percentage		100.00%	100.00%	100.00%	100.00%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | State, Local, and Other Governmental Programs [Member]
Net service revenues		$ 138,506	$ 113,002	$ 271,410	$ 220,756
Concentration Risk, Percentage		51.40%	53.10%	51.40%	52.50%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | Commercial Insurance [Member]
Net service revenues		$ 1,334	$ 1,467	$ 2,494	$ 2,953
Concentration Risk, Percentage		0.50%	0.70%	0.50%	0.70%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | Managed Care Organizations [Member]
Net service revenues		$ 121,900	$ 94,135	$ 238,907	$ 188,411
Concentration Risk, Percentage		45.30%	44.20%	45.30%	44.80%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | Private Pay [Member]
Net service revenues		$ 7,292	$ 3,689	$ 14,268	$ 7,595
Concentration Risk, Percentage		2.70%	1.70%	2.70%	1.80%
Customer Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | Other [Member]
Net service revenues		$ 151	$ 524	$ 390	$ 1,105
Concentration Risk, Percentage		0.10%	0.30%	0.10%	0.20%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member]
Net service revenues		$ 62,212	$ 56,030	$ 123,649	$ 111,893
Concentration Risk, Percentage		100.00%	100.00%	100.00%	100.00%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | ILLINOIS
Net service revenues		$ 14,419	$ 13,003	$ 28,983	$ 25,255
Concentration Risk, Percentage		23.20%	23.20%	23.40%	22.60%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | NEW MEXICO
Net service revenues		$ 8,184	$ 6,895	$ 16,097	$ 14,410
Concentration Risk, Percentage		13.20%	12.30%	13.00%	12.90%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | OHIO
Net service revenues		$ 23,204	$ 20,633	$ 46,391	$ 40,869
Concentration Risk, Percentage		37.30%	36.80%	37.50%	36.50%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Hospice Segment [Member] | All Other States [Member]
Net service revenues		$ 16,405	$ 15,499	$ 32,178	$ 31,359
Concentration Risk, Percentage		26.30%	27.70%	26.10%	28.00%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member]
Net service revenues		$ 18,048	$ 18,075	$ 36,033	$ 34,955
Concentration Risk, Percentage		100.00%	100.00%	100.00%	100.00%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | ILLINOIS
Net service revenues		$ 1,989	$ 3,042	$ 3,921	$ 5,984
Concentration Risk, Percentage		11.00%	16.80%	10.90%	17.10%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | NEW MEXICO
Net service revenues		$ 8,737	$ 8,300	$ 17,292	$ 16,077
Concentration Risk, Percentage		48.40%	45.90%	48.00%	46.00%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Home Health Segment [Member] | TENNESSEE
Net service revenues		$ 7,322	$ 6,733	$ 14,820	$ 12,894
Concentration Risk, Percentage		40.60%	37.30%	41.10%	36.90%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member]
Net service revenues		$ 269,183	$ 212,817	$ 527,469	$ 420,820
Concentration Risk, Percentage		100.00%	100.00%	100.00%	100.00%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | ILLINOIS
Net service revenues		$ 115,226	$ 110,774	$ 226,640	$ 218,349
Concentration Risk, Percentage		42.80%	52.10%	43.00%	51.90%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | NEW MEXICO
Net service revenues		$ 28,987	$ 28,644	$ 57,292	$ 57,611
Concentration Risk, Percentage		10.80%	13.50%	10.90%	13.70%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | NEW YORK
Net service revenues	[1]	$ (59)	$ 23,299	$ 214
Concentration Risk, Percentage	[1]	0.00%	10.90%	0.00%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | TEXAS
Net service revenues		$ 52,464	$ 0	$ 102,324	$ 0
Concentration Risk, Percentage		19.50%	0.00%	19.40%	0.00%
Geographic Concentration Risk [Member] | Revenue from Contract with Customer, Segment Benchmark [Member] | Personal Care Segment [Member] | All Other States [Member]
Net service revenues		$ 72,565	$ 50,100	$ 140,999	$ 98,027
Concentration Risk, Percentage		26.90%	23.50%	26.70%	23.30%

[1] As a result of changes and uncertainty in New York regarding the CDPAP, the Company determined that its New York personal care operations no longer fit its growth strategy and is divesting these operations. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture.

XML

Note 13 - Subsequent Events (Details Textual) $ in Millions	Aug. 01, 2025 USD ($)
Helping Hands [Member] | Subsequent Event [Member]
Business Combination, Consideration Transferred	$ 21.3